Cover Page
Cover Page - USD ($) $ in Billions | 12 Months Ended | ||
Jan. 31, 2021 | Feb. 26, 2021 | Jul. 31, 2020 | |
Cover [Abstract] | |||
Document Type | 10-K | ||
Document Annual Report | true | ||
Document Period End Date | Jan. 31, 2021 | ||
Current Fiscal Year End Date | --01-31 | ||
Document Transition Report | false | ||
Entity File Number | 001-38465 | ||
Entity Registrant Name | DOCUSIGN, INC. | ||
Entity Incorporation, State or Country Code | DE | ||
Entity Tax Identification Number | 91-2183967 | ||
Entity Address, Address Line One | 221 Main St. | ||
Entity Address, Address Line Two | Suite 1550 | ||
Entity Address, City or Town | San Francisco | ||
Entity Address, State or Province | CA | ||
Entity Address, Postal Zip Code | 94105 | ||
City Area Code | 415 | ||
Local Phone Number | 489-4940 | ||
Title of 12(b) Security | Common Stock, par value $0.0001 per share | ||
Trading Symbol | DOCU | ||
Security Exchange Name | NASDAQ | ||
Entity Well-known Seasoned Issuer | Yes | ||
Entity Voluntary Filers | No | ||
Entity Current Reporting Status | Yes | ||
Entity Interactive Data Current | Yes | ||
Entity Filer Category | Large Accelerated Filer | ||
Entity Small Business | false | ||
Entity Emerging Growth Company | false | ||
ICFR Auditor Attestation Flag | true | ||
Entity Shell Company | false | ||
Entity Public Float | $ 39.1 | ||
Entity Common Stock, Shares Outstanding | 193,087,560 | ||
Documents Incorporated by Reference | Portions of the definitive proxy statement for our 2021 Annual Meeting of Stockholders are incorporated by reference in Part III of this Form 10-K. We intend to file such proxy statement with the Securities and Exchange Commission (“the SEC”), within 120 days of the fiscal year ended January 31, 2021. | ||
Entity Central Index Key | 0001261333 | ||
Document Fiscal Year Focus | 2021 | ||
Document Fiscal Period Focus | FY | ||
Amendment Flag | false |
Consolidated Balance Sheets
Consolidated Balance Sheets - USD ($) $ in Thousands | Jan. 31, 2021 | Jan. 31, 2020 |
Current assets | ||
Cash and cash equivalents | $ 566,055 | $ 241,203 |
Investments—current | 207,450 | 414,939 |
Accounts receivable, net of allowance for doubtful accounts of $5,362 and $2,982 as of January 31, 2021 and 2020 | 323,570 | 237,841 |
Contract assets—current | 16,883 | 12,502 |
Prepaid expenses and other current assets | 48,390 | 37,405 |
Total current assets | 1,162,348 | 943,890 |
Investments—noncurrent | 92,717 | 239,729 |
Property and equipment, net | 165,039 | 128,293 |
Operating lease right-of-use assets | 159,352 | 149,833 |
Goodwill | 350,151 | 194,882 |
Intangible assets, net | 121,828 | 56,500 |
Deferred contract acquisition costs—noncurrent | 260,130 | 153,333 |
Other assets—noncurrent | 24,942 | 24,678 |
Total assets | 2,336,507 | 1,891,138 |
Current liabilities | ||
Accounts payable | 37,367 | 28,144 |
Accrued expenses and other current liabilities | 66,566 | 54,344 |
Accrued compensation | 156,158 | 83,189 |
Convertible senior notes—current | 20,469 | 0 |
Contract liabilities—current | 779,642 | 507,560 |
Operating lease liabilities—current | 32,971 | 20,728 |
Total current liabilities | 1,093,173 | 693,965 |
Convertible senior notes, net—noncurrent | 693,219 | 465,321 |
Contract liabilities—noncurrent | 16,492 | 11,478 |
Operating lease liabilities—noncurrent | 165,704 | 162,432 |
Deferred tax liability—noncurrent | 6,464 | 4,920 |
Other liabilities—noncurrent | 32,328 | 6,695 |
Total liabilities | 2,007,380 | 1,344,811 |
Commitments and contingencies (Note 11) | ||
Convertible senior notes (Note 9) | 3,390 | 0 |
Stockholders’ equity | ||
Preferred stock, $0.0001 par value; 10,000 shares authorized, 0 shares issued and outstanding as of January 31, 2021 and 2020 | 0 | 0 |
Common stock, $0.0001 par value; 500,000 shares authorized, 192,807 shares outstanding as of January 31, 2021; 500,000 shares authorized, 181,254 shares outstanding as of January 31, 2020 | 19 | 18 |
Treasury stock, at cost: 5 shares as of January 31, 2021; 0 shares as of January 31, 2020 | (1,048) | 0 |
Additional paid-in capital | 1,702,254 | 1,685,167 |
Accumulated other comprehensive income (loss) | 4,964 | (1,673) |
Accumulated deficit | (1,380,452) | (1,137,185) |
Total stockholders’ equity | 325,737 | 546,327 |
Total liabilities and equity | $ 2,336,507 | $ 1,891,138 |
Consolidated Balance Sheets (Pa
Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands | Jan. 31, 2021 | Jan. 31, 2020 |
Statement of Financial Position [Abstract] | ||
Allowance for doubtful accounts | $ (5,362) | $ (2,982) |
Preferred stock, par value (in usd per share) | $ 0.0001 | $ 0.0001 |
Preferred stock, shares authorized (in shares) | 10,000,000 | 10,000,000 |
Preferred stock, shares issued (in shares) | 0 | 0 |
Preferred stock, shares outstanding (in shares) | 0 | 0 |
Common stock, par value (in usd per share) | $ 0.0001 | $ 0.0001 |
Common stock, shares authorized (in shares) | 500,000,000 | 500,000,000 |
Common stock, shares outstanding (in shares) | 192,807,000 | 181,254,000 |
Treasury stock, shares (in shares) | 5,000 | 0 |
Consolidated Statements of Oper
Consolidated Statements of Operations and Comprehensive Loss - USD ($) shares in Thousands, $ in Thousands | 12 Months Ended | ||
Jan. 31, 2021 | Jan. 31, 2020 | Jan. 31, 2019 | |
Revenue: | |||
Total revenue | $ 1,453,047 | $ 973,971 | $ 700,969 |
Cost of revenue: | |||
Total cost of revenue | 364,058 | 243,234 | 192,421 |
Gross profit | 1,088,989 | 730,737 | 508,548 |
Operating expenses: | |||
Sales and marketing | 798,625 | 591,379 | 539,606 |
Research and development | 271,522 | 185,552 | 185,968 |
General and administrative | 192,697 | 147,315 | 209,297 |
Total operating expenses | 1,262,844 | 924,246 | 934,871 |
Loss from operations | (173,855) | (193,509) | (426,323) |
Interest expense | (30,799) | (29,254) | (10,844) |
Loss on extinguishment of debt | (33,752) | 0 | 0 |
Interest income and other income, net | 8,914 | 19,207 | 8,959 |
Loss before provision for (benefit from) income taxes | (229,492) | (203,556) | (428,208) |
Provision for (benefit from) income taxes | 13,775 | 4,803 | (1,750) |
Net loss | $ (243,267) | $ (208,359) | $ (426,458) |
Net loss per share attributable to common stockholders, basic and diluted (in usd per share) | $ (1.31) | $ (1.18) | $ (3.16) |
Weighted-average number of shares used in computing net loss per share attributable to common stockholders, basic and diluted (in shares) | 185,760 | 176,704 | 135,163 |
Other comprehensive income (loss): | |||
Foreign currency translation gains (losses), net of tax | $ 7,468 | $ (573) | $ (5,626) |
Unrealized gains (losses) on investments, net of tax | (831) | 865 | 258 |
Other comprehensive income (loss) | 6,637 | 292 | (5,368) |
Comprehensive loss | (236,630) | (208,067) | (431,826) |
Stock-based compensation expense included in costs and expenses: | |||
Stock-based compensation expense | 286,877 | 206,404 | 410,978 |
Sales and marketing | |||
Stock-based compensation expense included in costs and expenses: | |||
Stock-based compensation expense | 131,041 | 94,863 | 172,115 |
Research and development | |||
Stock-based compensation expense included in costs and expenses: | |||
Stock-based compensation expense | 65,890 | 43,211 | 74,108 |
General and administrative | |||
Stock-based compensation expense included in costs and expenses: | |||
Stock-based compensation expense | 47,288 | 39,745 | 122,715 |
Subscription | |||
Revenue: | |||
Total revenue | 1,381,397 | 918,463 | 663,657 |
Cost of revenue: | |||
Total cost of revenue | 259,992 | 163,931 | 117,764 |
Subscription | Cost of revenue | |||
Stock-based compensation expense included in costs and expenses: | |||
Stock-based compensation expense | 20,793 | 12,882 | 16,182 |
Professional services and other | |||
Revenue: | |||
Total revenue | 71,650 | 55,508 | 37,312 |
Cost of revenue: | |||
Total cost of revenue | 104,066 | 79,303 | 74,657 |
Professional services and other | Cost of revenue | |||
Stock-based compensation expense included in costs and expenses: | |||
Stock-based compensation expense | $ 21,865 | $ 15,703 | $ 25,858 |
Consolidated Statement of Redee
Consolidated Statement of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit) - USD ($) $ in Thousands | Total | Revision of Prior Period, Accounting Standards Update, Adjustment | Common Stock | Additional Paid-In Capital | Treasury Stock | Accumulated Other Comprehensive Income (Loss) | Accumulated Deficit | Accumulated DeficitRevision of Prior Period, Accounting Standards Update, Adjustment | Redeemable Convertible Preferred Stock |
Beginning balance (in shares) at Jan. 31, 2018 | 100,226,000 | ||||||||
Beginning balance at Jan. 31, 2018 | $ 547,501 | ||||||||
Redeemable Convertible Preferred Stock | |||||||||
Conversion of redeemable convertible preferred stock to common stock in connection with initial public offering (in shares) | (100,226,000) | ||||||||
Conversion of redeemable convertible preferred stock to common stock in connection with initial public offering | $ (547,854) | ||||||||
Accretion of preferred stock | $ (353) | $ 353 | |||||||
Ending balance (in shares) at Jan. 31, 2019 | 0 | ||||||||
Ending balance at Jan. 31, 2019 | $ 0 | ||||||||
Beginning balance (in shares) at Jan. 31, 2018 | 35,700,000 | ||||||||
Beginning balance at Jan. 31, 2018 | (338,648) | $ 4 | $ 160,265 | $ 3,403 | $ (502,320) | ||||
Total Stockholders’ Equity (Deficit) | |||||||||
Issuance of common stock in connection with initial public offering, net of offering costs (in shares) | 19,314,000 | ||||||||
Issuance of common stock in connection with initial public offering, net of offering costs | 524,979 | $ 2 | 524,977 | ||||||
Conversion of redeemable convertible preferred stock to common stock in connection with initial public offering (in shares) | 100,350,000 | ||||||||
Conversion of redeemable convertible preferred stock to common stock in connection with initial public offering | 547,854 | $ 10 | 547,844 | ||||||
Conversion of preferred stock warrant to common stock warrant in connection with initial public offering | 848 | 848 | |||||||
Equity component of convertible senior notes issuance | 131,331 | 131,331 | |||||||
Purchase of capped calls related to issuance of convertible senior notes | (67,563) | (67,563) | |||||||
Exercise of stock options (in shares) | 5,791,000 | ||||||||
Exercise of stock options | 50,211 | 50,211 | |||||||
Settlement of RSUs (in shares) | 8,126,000 | ||||||||
Settlement of RSUs | 0 | $ 1 | (1) | ||||||
Tax withholding on net share settlement of RSUs and employee stock purchase plan | (215,332) | (215,332) | |||||||
Employee stock-based compensation expense | 411,803 | 411,803 | |||||||
Non-employee stock-based compensation expense | 1,058 | 1,058 | |||||||
Accretion of preferred stock | (353) | (353) | |||||||
Exercise of common stock warrants (in shares) | 22,000 | ||||||||
Net loss | (426,458) | (426,458) | |||||||
Other comprehensive income, net | (5,368) | (5,368) | |||||||
Ending balance (in shares) at Jan. 31, 2019 | 169,303,000 | ||||||||
Ending balance at Jan. 31, 2019 | $ 614,362 | $ (48) | $ 17 | 1,545,088 | (1,965) | (928,778) | $ (48) | ||
Total Stockholders’ Equity (Deficit) | |||||||||
Accounting Standards Update [Extensible List] | us-gaap:AccountingStandardsUpdate201602Member | ||||||||
Accretion of preferred stock | $ 0 | ||||||||
Ending balance at Jan. 31, 2020 | 0 | ||||||||
Total Stockholders’ Equity (Deficit) | |||||||||
Exercise of stock options (in shares) | 6,737,000 | ||||||||
Exercise of stock options | 72,177 | $ 1 | 72,176 | ||||||
Settlement of RSUs (in shares) | 4,706,000 | ||||||||
Settlement of RSUs | 0 | ||||||||
Tax withholding on net share settlement of RSUs and employee stock purchase plan | (166,504) | (166,504) | |||||||
Employee stock purchase plan (in shares) | 508,000 | ||||||||
Employee stock purchase plan | 23,872 | 23,872 | |||||||
Employee stock-based compensation expense | 210,535 | 210,535 | |||||||
Net loss | (208,359) | (208,359) | |||||||
Other comprehensive income, net | 292 | 292 | |||||||
Ending balance (in shares) at Jan. 31, 2020 | 181,254,000 | ||||||||
Ending balance at Jan. 31, 2020 | 546,327 | $ 18 | 1,685,167 | $ 0 | (1,673) | (1,137,185) | |||
Redeemable Convertible Preferred Stock | |||||||||
Accretion of preferred stock | 0 | ||||||||
Ending balance at Jan. 31, 2021 | 3,390 | ||||||||
Total Stockholders’ Equity (Deficit) | |||||||||
Conversion of redeemable convertible preferred stock to common stock in connection with initial public offering (in shares) | 4,698,000 | ||||||||
Conversion of redeemable convertible preferred stock to common stock in connection with initial public offering | $ 1 | ||||||||
Reclassification to mezzanine equity for convertible senior notes due in 2023 | (3,390) | (3,390) | |||||||
Equity component of convertible senior notes issuance | 63,268 | 63,268 | |||||||
Purchase of capped calls related to issuance of convertible senior notes | (31,395) | (31,395) | |||||||
Issuance of common stock as consideration for acquisition (in shares) | 247,000 | ||||||||
Issuance of common stock as consideration for acquisition | $ 48,361 | 48,361 | |||||||
Exercise of stock options (in shares) | 2,072,000 | 2,072,000 | |||||||
Exercise of stock options | $ 24,305 | 24,305 | |||||||
Settlement of RSUs (in shares) | 4,072,000 | ||||||||
Settlement of RSUs | 0 | ||||||||
Tax withholding on net share settlement of RSUs and employee stock purchase plan | (377,590) | (376,542) | (1,048) | ||||||
Employee stock purchase plan (in shares) | 464,000 | ||||||||
Employee stock purchase plan | 29,859 | 29,859 | |||||||
Employee stock-based compensation expense | 294,554 | 294,554 | |||||||
Net loss | (243,267) | (243,267) | |||||||
Other comprehensive income, net | 6,637 | 6,637 | |||||||
Ending balance (in shares) at Jan. 31, 2021 | 192,807,000 | ||||||||
Ending balance at Jan. 31, 2021 | 325,737 | $ 19 | 1,702,254 | $ (1,048) | $ 4,964 | $ (1,380,452) | |||
Total Stockholders’ Equity (Deficit) | |||||||||
Stock Issued During Period, Value, Conversion of Convertible Securities, Net of Adjustments | $ (31,932) | $ (31,933) |
Consolidated Statements of Cash
Consolidated Statements of Cash Flows - USD ($) $ in Thousands | 12 Months Ended | ||
Jan. 31, 2021 | Jan. 31, 2020 | Jan. 31, 2019 | |
Cash flows from operating activities: | |||
Net loss | $ (243,267) | $ (208,359) | $ (426,458) |
Adjustments to reconcile net loss to net cash provided by operating activities | |||
Depreciation and amortization | 71,090 | 50,182 | 38,027 |
Amortization of deferred contract acquisition and fulfillment costs | 99,384 | 69,747 | 42,112 |
Amortization of debt discount and transaction costs | 28,001 | 26,389 | 9,507 |
Loss on extinguishment of debt | 33,752 | 0 | 0 |
Operating cash flow related to repayments of convertible senior notes | (75,165) | 0 | 0 |
Non-cash operating lease costs | 26,728 | 19,435 | 0 |
Stock-based compensation expense | 286,877 | 206,404 | 410,978 |
Deferred income taxes | (2,410) | 1,287 | (5,001) |
Other | (210) | (1,741) | 800 |
Changes in operating assets and liabilities | |||
Accounts receivable | (73,913) | (63,293) | (42,571) |
Contract assets | 1,912 | (1,508) | 4,204 |
Prepaid expenses and other current assets | (1,155) | (3,142) | (3,283) |
Deferred contract acquisition and fulfillment costs | (208,510) | (115,723) | (80,869) |
Other assets | (6,006) | 1,538 | 2,658 |
Accounts payable | 12,128 | 3,849 | (7,380) |
Accrued expenses and other liabilities | 37,155 | 9,353 | 6,449 |
Accrued compensation | 64,586 | 5,636 | 26,039 |
Contract liabilities | 267,750 | 130,266 | 100,874 |
Operating lease liabilities | (21,773) | (14,624) | 0 |
Net cash provided by operating activities | 296,954 | 115,696 | 76,086 |
Cash flows from investing activities: | |||
Cash paid for acquisition, net of acquired cash | (180,370) | 0 | (218,779) |
Purchases of marketable securities | (164,989) | (861,252) | (415,132) |
Sales of marketable securities | 28,986 | 0 | 0 |
Maturities of marketable securities | 488,538 | 627,309 | 0 |
Purchases of strategic investments | (5,300) | (15,500) | 0 |
Purchases of other investments | (3,241) | 0 | 0 |
Purchases of property and equipment | (82,395) | (72,046) | (30,413) |
Net cash (used in) provided by investing activities | 81,229 | (321,489) | (664,324) |
Cash flows from financing activities: | |||
Proceeds from issuance of convertible senior notes, net of initial purchasers' discounts and transaction costs | 677,370 | 0 | 560,756 |
Purchase of capped calls related to issuance of convertible senior notes | (31,395) | 0 | (67,563) |
Repayments of convertible senior notes | (384,199) | 0 | 0 |
Payment of revolving credit facility costs | (2,453) | 0 | 0 |
Proceeds from issuance of common stock in initial public offering, net of underwriting commissions | 0 | 0 | 529,305 |
Payment of tax withholding obligation on RSU settlement and ESPP purchase | (372,463) | (166,504) | (215,332) |
Proceeds from exercise of stock options | 24,305 | 72,177 | 50,211 |
Proceeds from employee stock purchase plan | 29,859 | 23,872 | 0 |
Payment of deferred offering costs | 0 | 0 | (4,011) |
Other financing | 0 | 0 | (250) |
Net cash (used in) provided by financing activities | (58,976) | (70,455) | 853,116 |
Effect of foreign exchange on cash, cash equivalents and restricted cash | 5,646 | (447) | (4,136) |
Net increase (decrease) in cash, cash equivalents and restricted cash | 324,853 | (276,695) | 260,742 |
Cash, cash equivalents and restricted cash at beginning of period | 241,483 | 518,178 | 257,436 |
Cash, cash equivalents and restricted cash at end of period | 566,336 | 241,483 | 518,178 |
Supplemental disclosure: | |||
Cash paid for interest | 78,040 | 2,852 | 204 |
Cash paid for operating lease liabilities | 35,176 | 22,034 | 0 |
Cash paid for income taxes | 3,503 | 1,970 | 3,213 |
Non-cash investing and financing activities: | |||
Property and equipment in accounts payable and accrued expenses and other current liabilities | 3,903 | 14,082 | 2,293 |
Operating lease right-of-use assets exchanged for lease obligations | 30,816 | 77,391 | 0 |
Fair value of shares issued as consideration for acquisition | 48,361 | 0 | 0 |
Fair value of shares issued as part of the repayments of convertible senior notes | 1,233,990 | 0 | 0 |
Conversion of redeemable convertible preferred stock to common stock in connection with initial public offering | 0 | 0 | 547,854 |
Conversion of preferred stock warrant to common stock warrant in connection with initial public offering | 0 | 0 | 848 |
Preferred stock accretion | 0 | 0 | 353 |
Recognition of build-to-suit lease | 0 | 0 | 2,479 |
Derecognition of build-to-suit lease | $ 0 | $ 2,479 | $ 0 |
Summary of Significant Accounti
Summary of Significant Accounting Policies | 12 Months Ended |
Jan. 31, 2021 | |
Accounting Policies [Abstract] | |
Summary of Significant Accounting Policies | Summary of Significant Accounting Policies Organization and Description of Business DocuSign, Inc. (“we,” “our” or “us”) was incorporated in the State of Washington in April 2003. We merged with and into DocuSign, Inc., a Delaware corporation, in March 2015. We provide a platform that enables businesses of all sizes to digitally prepare, sign, act on and manage agreements, thereby simplifying and accelerating the process of doing business. Basis of Presentation and Principles of Consolidation Our consolidated financial statements include those of DocuSign, Inc. and our subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. The accompanying consolidated financial statements have been prepared in accordance with United States (“U.S.”) generally accepted accounting principles (“GAAP”). Our fiscal year ends on January 31. References to fiscal 2021, for example, are to the fiscal year ended January 31, 2021. Certain prior year amounts have been reclassified to conform to current year presentation. These amounts were not material to any of the periods presented. Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions in the consolidated financial statements and notes thereto. Significant items subject to such estimates and assumptions made by management include, but are not limited to, the determination of: • the fair value of assets acquired and liabilities assumed in business combinations; • the average period of benefit associated with deferred contract acquisition costs and fulfillment costs; • the valuation of strategic investments; • the fair value of certain stock awards issued; • the f air value of the liability and equity components of convertible notes; • the useful life and recoverability of long-lived assets; • the discount rate used for operating leases; and • the recognition, measurement and valuation of deferred income taxes. The World Health Organization declared in March 2020 that the outbreak of the coronavirus disease named COVID-19 constitutes a global pandemic. We have undertaken measures to protect our employees, partners and customers. There can be no assurance that these measures will be effective, however, or that we can adopt them without adversely affecting our business operations. In addition, the COVID-19 pandemic has created and may continue to create significant uncertainty in global financial markets, which may decrease technology spending, depress demand for our products and harm our business and results of operations. As of the date of issuance of the financial statements, we are not aware of any specific event or circumstance that would require us to update our estimates, judgments or revise the carrying value of our assets or liabilities. These estimates may change, as new events occur and additional information is obtained, and are recognized in the consolidated financial statements as soon as they become known. Actual results could differ from those estimates and any such differences may be material to our financial statements. Concentration of Credit Risk Our financial instruments that are exposed to concentrations of credit risk consist primarily of cash, cash equivalents, marketable securities and accounts receivable. Although we deposit our cash with multiple financial institutions, the deposits, at times, may exceed federally insured limits. We have not experienced any losses on our deposits of cash and cash equivalents. Cash equivalents consist of money market funds which are invested through financial institutions in the U.S. Management believes that the institutions are financially stable and, accordingly, minimal credit risk exists. No customer individually accounted for more than 10% of our revenues in the years ended January 31, 2021, 2020 and 2019 or for more than 10% of our accounts receivable as of January 31, 2021 and 2020. We perform ongoing credit evaluations of our customers, do not require collateral and maintain allowances for potential credit losses on customers’ accounts using the expected loss model. Revenue Recognition We recognize revenue when a customer obtains control of promised services. We apply significant judgment in identifying and evaluating any terms and conditions in contracts which may impact revenue recognition. The amount of revenue recognized reflects the consideration that we expect to be entitled to receive in exchange for these services. To achieve the core principle of this standard, we apply the following steps: 1. Identification of the contract, or contracts, with the customer We consider the terms and conditions of the contract and our customary business practices in identifying our contracts under ASC 606. We determine we have a contract with a customer when the contract is approved, we can identify each party’s rights regarding the services to be transferred, we can identify the payment terms for the services, we have determined the customer has the ability and intent to pay and the contract has commercial substance. At contract inception we evaluate whether two or more contracts should be combined and accounted for as a single contract and whether the combined or single contract includes more than one performance obligation. We apply judgment in determining the customer’s ability and intent to pay, which is based on a variety of factors, including the customer’s historical payment experience or, in the case of a new customer, credit and financial information pertaining to the customer. 2. Identification of the performance obligations in the contract Performance obligations promised in a contract are identified based on the services and the products that will be transferred to the customer that are both capable of being distinct, whereby the customer can benefit from the service either on its own or together with other resources that are readily available from third parties or from us, and are distinct in the context of the contract, whereby the transfer of the services and the products is separately identifiable from other promises in the contract. Our performance obligations consist of (i) subscription services, (ii) professional services, (iii) on-premises solutions, and (iv) maintenance and support for on-premises solutions. 3. Determination of the transaction price The transaction price is determined based on the consideration to which we expect to be entitled in exchange for transferring services to the customer. Variable consideration is included in the transaction price if, in our judgment, it is probable that a significant future reversal of cumulative revenue under the contract will not occur. None of our contracts contain a significant financing component. 4. Allocation of the transaction price to the performance obligation in the contract If the contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. Contracts that contain multiple performance obligations require an allocation of the transaction price to each performance obligation based on a relative standalone selling price ("SSP"). 5. Recognition of the revenue when, or as, we satisfy a performance obligation Revenue is recognized at the time the related performance obligation is satisfied by transferring the control of the promised service to a customer. Revenue is recognized as control of the service is transferred to the customer, in an amount that reflects the consideration that we expect to receive in exchange for those services. We generate all our revenue from contracts with customers. Subscription Revenue We generate revenue primarily from sales of subscriptions to access our software suite and related subscriptions of our customers. Our subscription revenue is driven by our go-to-market model, which includes a combination of direct sales, partner-assisted sales and web-based self-service purchasing. Subscription arrangements with customers do not provide the customer with the right to take possession of our software operating our software suite at any time. Instead, customers are granted continuous access to our software suite over the contractual period. A time-elapsed method is used to measure progress because we transfer control evenly over the contractual period. Accordingly, the fixed consideration related to subscription revenue is generally recognized on a straight-line basis over the contract term beginning on the date access to our software suite is provided. Professional Services and Other Revenue Professional services and other revenue consists of fees associated with consulting and training services from assisting customers in implementing and expanding the use of our software suite. These services are generally distinct from subscription services. Professional services do not result in significant customization of the subscription service. Revenue from professional services provided on a time and materials basis is recognized as the services are performed. Other revenue includes amounts derived from the sale of our on-premises solutions, which are recognized upon passage of control, which occurs upon shipment of the product. The maintenance and support on the on-premises solutions is a stand-ready obligation to perform this service over the term of the arrangement and, as a result, is accounted for ratably over the term of the arrangement. Contracts with Multiple Performance Obligations Most of our contracts with customers contain multiple performance obligations that are distinct and accounted for separately. The transaction price is allocated to the separate performance obligations on a relative SSP basis. We determine SSP for our performance obligations based on our observable inputs, such as standalone sales and historical contract pricing. SSP is consistent with our overall pricing objectives, taking into consideration the type of subscription services and professional and other services. Variable Consideration Revenue from sales is recorded at the net sales price, which is the transaction price, and includes estimates of variable consideration. The amount of variable consideration that is included in the transaction price is constrained and is included in the net sales price only to the extent that it is probable that a significant reversal in the amount of the cumulative revenue will not occur when the uncertainty is resolved. If our services do not meet certain service level commitments, our customers are entitled to receive service credits, and in certain cases, refunds, each representing a form of variable consideration. We have historically not experienced any significant incidents affecting the defined levels of reliability and performance as required by our subscription contracts. Accordingly, the amount of any estimated refunds related to these agreements in the consolidated financial statements is not material during the periods presented. Deferred Contract Acquisition Costs We capitalize sales commissions, certain parts of the company bonus and associated payroll taxes paid to internal sales personnel that are incremental to the acquisition of customer contracts as deferred contract acquisition costs in "Prepaid expenses and other current assets" and "Deferred contract acquisition costs—noncurrent" on our consolidated balance sheets. We determine whether costs should be deferred based on our sales compensation plans, if the commissions are in fact incremental and would not have occurred absent the customer contract. These deferred commissions are amortized on a straight-line basis over the periods of benefit, commensurate with the pattern of revenue recognition. Commissions paid for renewal of a subscription contract are not considered commensurate with the commissions paid for the acquisition of the initial subscription contract given the substantive difference in commission rates between new and renewal contracts. The period of benefit for commissions paid for the acquisition of the initial subscription contract, of five years, is determined by taking into consideration our initial estimated customer life and the technological life of our software suite and related significant features. The period of benefit for renewal subscription contracts, of two years, is determined by considering the average contractual term for renewal contracts. Commissions paid on professional services contracts are amortized over the period of benefit, being the period the associated revenue is earned as the commissions paid on new and renewal professional services contracts are commensurate with each other. Amortization of deferred contract acquisition costs is primarily included in the “Sales and marketing” expense in the consolidated statements of operations and comprehensive loss. We periodically review these deferred costs to determine whether events or changes in circumstances have occurred that could impact the period of benefit of these deferred contract acquisition costs. There were no material impairment losses recorded during the periods presented. Deferred Contract Fulfillment Costs We capitalize third-party costs to fulfill contracts with a customer in “Prepaid expenses and other current assets” and “Other assets—noncurrent” on our consolidated balance sheets. We amortize these costs on a straight-line basis consistent with the ratable revenue recognition of the performance obligations in the associated contracts. Cost of Revenue “Subscription” cost of revenue primarily consists of personnel and related costs to support our software suite, amortization expense associated with capitalized internally-developed software and technology-related intangible assets, property and equipment depreciation, allocated overhead expenses, merchant processing fees and server hosting costs. “Professional services and other” cost of revenue consists primarily of personnel costs for our professional services delivery team, travel-related costs and allocated overhead. Advertising Advertising costs are expensed as incurred and are included in “Sales and marketing” expense in our consolidated statements of operations and comprehensive loss. Advertising expense was $78.6 million, $41.6 million and $34.1 million in the years ended January 31, 2021, 2020 and 2019. Research and Development Research and development costs are expensed as incurred and consist primarily of personnel costs, including salaries, bonuses and benefits, and stock-based compensation. Stock-Based Compensation Compensation cost for stock-based awards issued to employees, including stock options, employee stock purchase plan (“ESPP”) purchase rights and restricted stock units (“RSUs”), is measured at fair value on the date of grant and recognized over the service period, generally on a straight-line basis. The fair value of stock options and ESPP purchase rights is estimated on the date of grant using a Black-Scholes option-pricing model. The fair value of RSUs is estimated on the date of grant based on the fair value of our underlying common stock. From time to time, we grant RSUs that also include performance-based or market-based conditions. For RSUs granted with a market condition, we use a lattice model simulation analysis to value the RSUs. Compensation expense for RSUs granted prior to January 31, 2018, is recognized on a graded basis over the requisite service period. Such RSUs contain a performance condition in the form of a specified liquidity event which was satisfied upon the effectiveness of our registration statement on Form S-1 (“IPO Registration Statement”) on April 26, 2018. On that date we recorded a cumulative stock-based compensation expense of $262.8 million using the accelerated attribution method for all the RSUs, for which the service condition has been fully satisfied as of April 26, 2018. The remaining unrecognized stock-based compensation expense related to the RSUs will be recorded over their remaining requisite service periods. RSUs granted after January 31, 2018, generally vest only on the satisfaction of service-based condition. Compensation expense for RSUs granted with a market or a performance condition is recognized on a graded vesting basis over the requisite service period. The amount of compensation expense related to the RSUs granted with a performance condition is determined after assessing the probability of achieving requisite performance criteria. We recognize compensation expense related to shares issued pursuant to the 2018 ESPP on a straight-line basis over the offering period of six months. Compensation expense is recognized net of forfeitures that are estimated at the time of grant and revised in subsequent periods if actual forfeitures differ from those estimates. We capitalize stock-based compensation costs incurred as a result of qualifying internally-developed software development activities. We may elect to issue shares on the settlement dates net of the statutory tax withholding requirements to be paid by us on behalf of our employees. In these instances, we record the liability for withholding amounts to be paid by us as treasury stock or as a reduction to additional paid-in capital, and include these payments as a reduction of cash flows from financing activities. Income Taxes We use the asset and liability method of accounting for income taxes. Under this method, income tax expense is recognized for the amount of taxes payable or refundable for the current year. In addition, deferred tax assets and liabilities are recognized for expected future tax consequences of temporary differences between the financial reporting and tax basis of assets and liabilities, and for operating losses and tax credit carryforwards. We record a valuation allowance to reduce our deferred tax assets to an amount for which realization is more likely than not. Foreign Currency The functional currency of our foreign entities and branches is generally the local currency. Monetary assets and liabilities and transactions denominated in currencies other than an entity's functional currency are remeasured into its functional currency using current exchange rates, whereas nonmonetary assets and liabilities are remeasured using historical exchange rates. We recognize gains and losses from such remeasurements within “Interest income and other income, net” in the consolidated statements of operations and comprehensive loss in the period of occurrence. We recorded a foreign currency transaction gain of $1.9 million for the year ended January 31, 2021 and foreign currency transaction losses of $1.0 million and $3.4 million for the years ended January 31, 2020 and 2019. We present our financial statements in U.S. dollars. Adjustments resulting from translating foreign functional currency financial statements into U.S. dollars are recorded as a separate component on our consolidated statements of comprehensive loss, net of tax. All assets and liabilities denominated in a foreign currency are translated at the exchange rate on the balance sheet date. Revenues and expenses are translated at the average exchange rate during the period. Equity transactions are translated using the historical exchange rate. Net Loss Per Share Attributable to Common Stockholders In periods when we have net income, we compute basic and diluted net loss per share in conformity with the two-class method required for participating securities. The undistributed earnings are allocated between common stock and participating securities as if all earnings had been distributed during the period presented. We consider all series of convertible preferred stock to be participating securities as the holders of such stock are entitled to receive noncumulative dividends on a pari passu basis in the event that a dividend is paid on common stock. We also consider any shares issued on the early exercise of stock options subject to repurchase to be participating securities because holders of such shares have non-forfeitable dividend rights in the event a dividend is paid on common stock. The holders of convertible preferred stock and early exercised shares do not have a contractual obligation to share in our losses. As such, our net losses in all the years presented were not allocated to these participating securities. Basic net loss per share attributable to common stockholders is computed by dividing the net loss attributable to common stockholders by the weighted-average number of shares of common stock outstanding during the period. Diluted net loss per share attributable to common stockholders is computed by giving effect to all potential shares of common stock, including shares underlying our convertible senior notes, unvested RSUs, early exercised or outstanding stock options, ESPP purchase rights, convertible preferred stock, and warrants to purchase common stock and convertible preferred stock, to the extent they are dilutive. Since we have reported net losses for all periods presented, dilutive common shares are not assumed to have been issued as their effect would have been antidilutive. Therefore, diluted net loss per share attributable to common stockholders is the same as basic net loss per share attributable to common stockholders. Cash and Cash Equivalents Cash and cash equivalents consist of money market funds, highly liquid investments with original maturities of three months or less at the date of purchase and deposits with financial institutions and are carried at fair value. Investments Investments in marketable securities consist of commercial paper, corporate notes and bonds, as well as U.S. Treasury and government agency securities. Management determines the appropriate classification of investments at the time of purchase and reevaluates such determination at each balance sheet date. Marketable securities are classified as available-for-sale and are carried at fair value in the consolidated balance sheet and are classified as short-term or long-term based on their remaining contractual maturities. We evaluate our investments with unrealized loss positions at the individual security level to determine whether the unrealized loss was related to credit or noncredit factors. We consider whether a credit loss exists based on the extent of the unrealized loss position, any adverse conditions specifically related to the security or the issuer's operating environment, pay structure of the security, the issuer's payment history and any changes in the issuer's credit rating. Estimated credit losses are determined using a discounted cash flow model and recorded as an allowance, with changes in expected credit losses on our investments recorded in “Interest income and other income, net” in the consolidated statements of operations and comprehensive loss. Unrealized gains and losses related to noncredit factors are reflected in “Accumulated other comprehensive income (loss)” on the consolidated balance sheets. Prior to February 1, 2020, the date of the adoption of ASU 2016-13 and ASU 2019-04, we evaluated our investments to assess whether those with unrealized loss positions were other than temporarily impaired. We considered impairments to be other than temporary if they were related to deterioration in credit risk or if it is likely we will sell the securities before the recovery of their cost basis. Realized gains and losses and declines in value judged to be other than temporary were determined based on the specific identification method and reported in “Interest income and other income, net” in the consolidated statements of operations and comprehensive loss. Strategic Investments Our strategic investments consist of non-marketable equity investments in privately-held companies in which we do not have a controlling interest or significant influence. We have elected to apply the measurement alternative for equity investments that do not have readily determinable fair values, measuring them at cost, less any impairment, plus or minus adjustments resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer. An impairment loss is recorded when an event or circumstance indicates a decline in value has occurred. As of January 31, 2021 and 2020, we held equity investments in privately-held companies totaling $6.0 million and $15.5 million that are classified in “Other assets—noncurrent” on our consolidated balance sheets. As there have been no material observable price changes, we have not recorded any adjustments resulting from observable price changes for identical or similar investments or impairment charges for any of our equity investments in privately-held companies. Restricted Cash Restricted cash consists of certificates of deposits collateralizing our operating lease agreements for office space. The following table illustrates the reconciliation of cash, cash equivalents, and restricted cash shown in the consolidated statements of cash flows as of January 31, 2021 and 2020: January 31, (in thousands) 2021 2020 Cash and cash equivalents $ 566,055 $ 241,203 Restricted cash included in prepaid expense and other current assets — 280 Restricted cash included in other assets - noncurrent 281 — Total cash, cash equivalents, and restricted cash shown in the statement of cash flows $ 566,336 $ 241,483 Fair Value of Financial Instruments We measure assets and liabilities at fair value based on an expected exit price, which represents the amount that would be received on the sale of an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value may be based on assumptions that market participants would use in pricing an asset or liability. The authoritative guidance on fair value measurements establishes a consistent framework for measuring fair value on either a recurring or nonrecurring basis whereby inputs, used in valuation techniques, are assigned a hierarchical level. The following are the hierarchical levels of inputs to measure fair value: Level 1 Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets. Level 2 Inputs reflect quoted prices for identical assets or liabilities in markets that are not active; quoted prices for similar assets or liabilities in active markets; inputs other than quoted prices that are observable for the assets or liabilities; or inputs that are derived principally from or corroborated by observable market data by correlation or other means. Level 3 Unobservable inputs reflecting our own assumptions incorporated in valuation techniques used to determine fair value. These assumptions are required to be consistent with market participant assumptions that are reasonably available Assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. Our assessment of the significance of a particular input to the fair value measurement requires judgment and may affect the placement of assets and liabilities being measured within the fair value hierarchy. The carrying values of cash, accounts receivable and accounts payable approximate their respective fair values due to the short period of time to maturity, receipt or payment. Accounts Receivable, Unbilled Accounts Receivable and Allowance for Doubtful Accounts Accounts receivable primarily consist of amounts billed currently due from customers. Our accounts receivable are subject to collection risk. Gross accounts receivable are reduced for this risk by an allowance for doubtful accounts. This allowance is for estimated losses resulting from the inability of our customers to make required payments. Our allowance for doubtful accounts includes balances that are specifically identified for adequacy based on a regular evaluation of such factors as age of the receivable balance, current economic conditions, credit quality of the customer, and past collection experience. We also include in our allowance for doubtful accounts an estimate for future credit losses, based on historical experience, which is recorded in the period in which we invoice our customers starting February 1, 2020, the date of the adoption of ASU 2016-13 and ASU 2019-04. We do not have any off-balance-sheet credit exposure related to our customers. Unbilled accounts receivable represent amounts for which we have recognized revenue, pursuant to our revenue recognition policy, and have an unconditional right to consideration prior to invoicing the customer. The unbilled accounts receivable balance was $3.6 million and $1.6 million as of January 31, 2021 and 2020. We do not typically offer right of refund in our contracts and do not require collateral from our customers. Changes in the allowance for doubtful accounts were not material in all periods presented. Property and Equipment Property and equipment, including costs incurred to bring to the location and condition necessary for intended use, are recorded at cost and depreciated over their estimated useful lives using the straight-line method and the following estimated useful lives: Estimated Useful Life Computer and network equipment 3 years Software, including capitalized software development costs 3 - 5 years Furniture and office equipment 3 - 4 years Leasehold improvements Lesser of lease term and 10 years Disposals are removed at cost less accumulated depreciation, and any gain or loss from disposition is reflected in the statement of operations in the year of disposition. Additions and improvements that increase the value or extend the life of an asset are capitalized. Maintenance and repairs are expensed as incurred. Leases On February 1, 2019, we adopted Accounting Standards Update (“ASU”) No. 2016-02, Leases (Topic 842) using the modified retrospective approach and applied the related optional practical expedients. Leases arise from contractual obligations that convey the right to control the use of identified property, plant or equipment for a period of time in exchange for consideration. We determine whether an arrangement is or contains a lease at inception, based on whether there is an identified asset and whether we control the use of the identified asset throughout the period of use. At lease commencement date, we determine lease classification between finance and operating, allocate the consideration to the lease and nonlease components and recognize a right-of-use asset and corresponding lease liability for each lease component. A right-of-use asset represents our right to use an underlying asset and a lease liability represents our obligation to make payments during the lease term. The lease liability is initially measured as the present value of the remaining lease payments over the lease term. The discount rate used to determine the present value is our incremental borrowing rate unless the interest rate implicit in the lease is readily determinable. We estimate our incremental borrowing rate based on the information available at lease commencement date for borrowings with a similar term. The right-of-use asset is initially measured as the present value of the lease payments, adjusted for initial direct costs, prepaid lease payments to lessors and lease incentives. Our operating lease right-of-use assets and liabilities recognized at February 1, 2019, the adoption date of Topic 842, were based on the present value of lease payments over the remaining lease term as of that date, using the incremental borrowing rate as of that date. We do not recognize right-of-use assets and liabilities for leases with a term of twelve months or less. Additionally, we do not separate nonlease components from the associated lease components for our office leases and certain other asset classes. The total consideration includes fixed payments and contractual escalation provisions. We are responsible for maintenance, insurance, property taxes and other variable payments, which are expensed as incurred. Our leases include options to renew or terminate. We include the option to renew or terminate in our determination of the lease term when the option is deemed to be reasonably assured to be exercised. Operating leases are classified in “Operating lease right-of-use assets”, “Operating lease liabilities—current”, and “Operating lease liabilities—noncurrent” on our consolidated balance sheets. Operating lease expense is recognized on a straight-line basis over the expected lease term and included in “Loss from operations” in our consolidated statements of operations and comprehensive loss. Goodwill Good |
Revenue and Performance Obligat
Revenue and Performance Obligations | 12 Months Ended |
Jan. 31, 2021 | |
Revenue from Contract with Customer [Abstract] | |
Revenue and Performance Obligations | Revenue and Performance Obligations Subscription revenue is recognized over time and accounted for approximately 95%, 94% and 95% of our revenue for the years ended January 31, 2021, 2020 and 2019. As of January 31, 2021, the amount of the transaction price allocated to remaining performance obligations for contracts greater than one year was $1.1 billion. We expect to recognize 52% of the transaction price allocated to remaining performance obligations within the 12 months following January 31, 2021 in our consolidated statement of operations and comprehensive loss. Contract assets represent amounts for which we have recognized revenue, pursuant to our revenue recognition policy, for contracts that have not yet been invoiced to our customers where there is a remaining performance obligation, typically for multi-year arrangements. Total contract assets were $17.5 million and $13.4 million as of January 31, 2021 and 2020, of which $0.6 million and $0.9 million were noncurrent and included within “ Other assets—noncurrent ” on our consolidated balance sheets. The change in contract assets reflects the difference in timing between our satisfaction of remaining performance obligations and our contractual right to bill our customers. Contract liabilities consist of deferred revenue and include payments received in advance of performance under the contract. Such amounts are generally recognized as revenue over the contractual period. For the years ended January 31, 2021 , 2020 and 2019, we recognized revenue of $499.5 million , $374.8 million and $264.0 million that was included in the corresponding contract liability balance at the beginning of the periods presented. We receive payments from customers based upon contractual billing schedules. We record accounts receivable when the right to consideration becomes unconditional. Payment terms on invoiced amounts are typically 30 days. The following table represents a rollforward of our deferred contract acquisition and fulfillment costs: Year Ended January 31, (in thousands) 2021 2020 Deferred Contract Acquisition Costs Beginning balance $ 155,697 $ 115,985 Additions to deferred contract acquisition costs 185,970 99,382 Amortization of deferred contract acquisition costs (81,132) (58,192) Cumulative translation adjustment 1,984 (1,478) Ending balance $ 262,519 $ 155,697 Deferred Contract Fulfillment Costs Beginning balance $ 8,218 $ 3,432 Additions to deferred contract fulfillment costs 22,540 16,341 Amortization of deferred contract fulfillment costs (18,252) (11,555) Ending balance $ 12,506 $ 8,218 |
Fair Value Measurements
Fair Value Measurements | 12 Months Ended |
Jan. 31, 2021 | |
Fair Value Disclosures [Abstract] | |
Fair Value Measurements | Fair Value Measurements The following table summarizes our financial assets that are measured at fair value on a recurring basis: January 31, 2021 (in thousands) Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Estimated Fair Value Level 1: Cash equivalents (1) Money market funds $ 284,312 $ — $ — $ 284,312 Level 2: Available-for-sale securities Commercial paper 42,048 1 (23) 42,026 Corporate notes and bonds 199,277 375 (67) 199,585 U.S. Treasury securities 4,998 — — 4,998 U.S. government agency securities 53,052 12 (6) 53,058 Level 2 total 299,375 388 (96) 299,667 Level 3: Available-for-sale securities Corporate notes and bonds 500 — — 500 Total $ 584,187 $ 388 $ (96) $ 584,479 January 31, 2020 (in thousands) Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Estimated Fair Value Level 1: Cash equivalents (1) Money market funds $ 165,424 $ — $ — $ 165,424 Level 2: Available-for-sale securities Commercial paper 14,919 7 (1) 14,925 Corporate notes and bonds 372,844 891 (31) 373,704 U.S. Treasury securities 90,697 153 (1) 90,849 U.S. government agency securities 175,086 153 (49) 175,190 Level 2 total 653,546 1,204 (82) 654,668 Total $ 818,970 $ 1,204 $ (82) $ 820,092 (1) Included in "cash and cash equivalents" in our consolidated balance sheets as of January 31, 2021 and 2020, in addition to cash of $281.7 million and $75.8 million We use quoted prices in active markets for identical assets to determine the fair value of our Level 1 investments. The fair value of our Level 2 investments is determined using pricing based on quoted market prices or alternative market observable inputs . The fair value of our Level 3 investments is determined based on an income approach using unobservable inputs. The fair value of our available-for-sale securities as of January 31, 2021, by remaining contractual maturities, were as follows (in thousands): Due in one year or less $ 207,450 Due in one to two years 92,717 $ 300,167 As of January 31, 2021, we had a total of 93 available-for-sale securities, with 42 securities in an unrealized loss position. An allowance for credit losses was deemed unnecessary for these securities, given the extent of the unrealized loss positions as well as the issuers' high credit ratings and consistent payment history. As of January 31, 2020, we had a total of 178 available-for-sale securities, none of which were considered to be other-than-temporarily impaired. We had no liabilities measured at fair value on recurring basis as of January 31, 2021 and 2020. Convertible Senior Notes We estimated the fair value based on the quoted market prices in an inactive market on the last trading day of the reporting period (Level 2). The Notes are recorded at face value less unamortized debt discount and transaction costs as “Convertible senior notes, net—noncurrent” and “Convertible senior notes—current.” Refer to Note 9 for further information. January 31, (in thousands) 2021 2020 0.5% Convertible Senior Notes due in 2023 Aggregate principal amount $ 115,000 $ 575,000 Fair value amount 373,928 743,504 0.0% Convertible Senior Notes due in 2024 Aggregate principal amount $ 690,000 $ — Fair value amount 725,100 — |
Property and Equipment, Net
Property and Equipment, Net | 12 Months Ended |
Jan. 31, 2021 | |
Property, Plant and Equipment [Abstract] | |
Property and Equipment, Net | Property and Equipment, Net Property and equipment consisted of the following: January 31, (in thousands) 2021 2020 Computer and network equipment $ 102,163 $ 66,937 Software, including capitalized software development costs 56,858 33,373 Furniture and office equipment 21,682 16,752 Leasehold improvements 79,892 59,564 260,595 176,626 Less: Accumulated depreciation (121,029) (81,228) 139,566 95,398 Work in progress 25,473 32,895 $ 165,039 $ 128,293 Depreciation and amortization expenses associated with property and equipment was $45.5 million, $32.5 million and $24.9 million in the years ended January 31, 2021, 2020 and 2019. This included amortization expense related to capitalized internally-developed software costs of $6.2 million, $4.1 million and $2.8 million in the respective years . |
Acquisitions
Acquisitions | 12 Months Ended |
Jan. 31, 2021 | |
Business Combinations [Abstract] | |
Acquisitions | Acquisitions Acquisition of Seal Software Group Limited On May 1, 2020, we completed the acquisition of Seal Software Group Limited (“Seal”), a contract analytics and artificial intelligence (“AI”) technology provider headquartered in Walnut Creek, California. The acquisition allows us to integrate Seal's technology comprehensively across the DocuSign Agreement Cloud to deliver increased functionality to companies using the Agreement Cloud to prepare, sign, act on and manage agreements. Under the terms of the purchase agreement, we paid $184.7 million in cash, net of cash acquired, transaction costs and working capital adjustments, for Seal’s outstanding stock. Prior to the acquisition, we held a $15.0 million minority investment in Seal’s outstanding stock. As of the acquisition, the fair value of our minority interest, calculated as the difference between the total acquisition consideration and the portion attributable to third party Seal shareholders, approximated the carrying value. Additionally, to certain continuing employees of Seal, we granted restricted stock units with service and performance conditions covering up to 0.1 million shares of our common stock with an aggregate grant date fair value of $11.4 million that will be accounted for as a post-acquisition compensation expense over the vesting period. The performance-based condition was based on Seal meeting certain bookings targets for the year ended January 31, 2021 and that performance condition was not met. We accounted for the transaction as a business combination using the acquisition method of accounting. We allocated the purchase price to the tangible and identifiable intangible assets acquired and liabilities assumed based on their respective estimated fair values on the acquisition date. Fair values were determined using the income and cost approaches. Excess purchase price consideration was recorded as goodwill and is primarily attributable to the assembled workforce and expanded market opportunities when integrating Seal’s AI and analytics capabilities within our existing product offering. The following table summarizes the acquisition date fair values of assets acquired and liabilities assumed at the date of acquisition: (in thousands) As Adjusted Cash and cash equivalents $ 729 Accounts receivable 9,654 Contract assets 5,813 Prepaid expense and other assets 5,854 Property and equipment 915 Goodwill 114,663 Intangible assets 83,700 Right-of-use Assets 3,130 Accounts payable (854) Accrued compensation (2,697) Contract liabilities (7,745) Accrued expenses and other liabilities (6,499) Lease liabilities (3,126) Deferred tax liability—noncurrent (3,084) $ 200,453 $5.3 million of the goodwill recognized upon acquisition is deductible for U.K. income tax purposes, where Seal is registered. No amount of the goodwill recognized upon acquisition is deductible for U.S. federal income tax purposes. The estimated useful lives of intangible assets, primarily based on the expected period of benefit to us, and fair values of the identifiable intangible assets at acquisition date were as follows: (in thousands, except years) Estimated Fair Value Weighted Average Useful Life Existing technology $ 37,400 5 years Customer relationships—subscription 41,700 10 years Backlog—subscription 4,600 2 years Total intangible assets $ 83,700 7.3 years In the year ended January 31, 2021, we incurred acquisition costs of $6.2 million. These costs included legal, accounting fees and other costs directly related to the acquisition of Seal and are recognized within operating expenses in our consolidated statements of operations. In the year ended January 31, 2021, we recognized revenues from Seal of $16.3 million and net losses of $20.1 million, excluding the impact of acquired intangible asset amortization. The results of operations of Seal were included in our consolidated statements of operations from the acquisition date. The following unaudited pro forma information has been prepared for illustrative purposes only and assumes the acquisition occurred on February 1, 2019. It includes pro forma adjustments related to the amortization of acquired intangible assets, share-based compensation expense, professional services revenue and contract acquisitions costs adjustments under the new revenue recognition standard, and contract liabilities fair value adjustment. The unaudited pro forma results have been prepared based on estimates and assumptions, which we believe are reasonable, however, they are not necessarily indicative of the consolidated results of operations had the acquisition occurred on February 1, 2019, or of future results of operations: Year Ended January 31, (in thousands) (unaudited) 2021 2020 Revenue $ 1,464,424 $ 1,001,809 Net loss (246,819) (262,968) Net loss per share attributable to common stockholders, basic and diluted $ (1.33) $ (1.49) Acquisition of Liveoak Technologies, Inc. On July 6, 2020, we completed the acquisition of Liveoak Technologies, Inc. (“Liveoak”), a virtual customer engagement and business platform based in Austin, Texas. The company’s platform includes several technologies specific to remote agreements, such as video conferencing, video identity verification, collaborative form-filling, an integration with DocuSign eSignature, and a detailed audit trail. The acquisition enables us to leverage Liveoak’s technology and expertise to accelerate the launch of DocuSign Notary, a new product for remote online notarization, where signers and the notary public are in different places. The consideration to acquire Liveoak’s outstanding stock was $48.4 million, which consisted primarily of the fair value of our common stock issued and the fair value of stock options issued to substitute vested Liveoak options. We recorded approximately $39.9 million of goodwill which is primarily attributed to the assembled workforce and expanded market opportunities for integrating Liveoak’s technology with our existing product offering. None of the goodwill recognized upon acquisition was deductible for U.S. federal income tax purposes. In the year ended January 31, 2021, we incurred costs of $1.8 million directly related to the acquisition of Liveoak. These costs are recognized within operating expenses in our consolidated statements of operations. We included the results of operations of Liveoak in our consolidated statements of operations from the acquisition date. These results were not material to our consolidated statements of operations for the year ended January 31, 2021 . |
Goodwill and Intangible Assets,
Goodwill and Intangible Assets, Net | 12 Months Ended |
Jan. 31, 2021 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Goodwill and Intangible Assets, Net | Goodwill and Intangible Assets, Net The changes in the carrying amount of goodwill were as follows (in thousands): Balance at January 31, 2019 $ 195,225 Foreign currency translation (343) Balance at January 31, 2020 194,882 Additions—Seal 114,663 Additions—Liveoak 39,892 Foreign currency translation 714 Balance at January 31, 2021 $ 350,151 Intangible assets consisted of the following: As of January 31, 2021 As of January 31, 2020 (in thousands, except years) Weighted-average Remaining Useful Life (Years) Estimated Fair Value Accumulated Amortization Acquisition-related Intangibles, Net Estimated Fair Value Accumulated Amortization Acquisition-related Intangibles, Net Existing technology 3.9 $ 72,994 $ (35,613) $ 37,381 $ 31,594 $ (25,164) $ 6,430 Customer contracts & related relationships 7.9 110,082 (29,393) 80,689 65,782 (19,071) 46,711 Other 1.2 22,534 (19,356) 3,178 17,234 (14,509) 2,725 6.5 $ 205,610 $ (84,362) 121,248 $ 114,610 $ (58,744) 55,866 Cumulative translation adjustment 580 634 Total $ 121,828 $ 56,500 Amortization of finite-lived intangible assets was as follows: Year Ended January 31, (in thousands) 2021 2020 2019 Cost of subscription revenue $ 11,052 $ 5,704 $ 6,081 Sales and marketing 14,566 12,013 7,021 Total $ 25,618 $ 17,717 $ 13,102 As of January 31, 2021, future amortization of finite-lived intangible assets that will be recorded in cost of revenue and operating expenses is estimated as follows, excluding cumulative translation adjustment: Fiscal Period Amount 2022 $ 24,282 2023 19,906 2024 18,575 2025 17,998 2026 12,388 Thereafter 28,099 Total $ 121,248 |
Contract Balances
Contract Balances | 12 Months Ended |
Jan. 31, 2021 | |
Revenue from Contract with Customer [Abstract] | |
Contract Balances | Revenue and Performance Obligations Subscription revenue is recognized over time and accounted for approximately 95%, 94% and 95% of our revenue for the years ended January 31, 2021, 2020 and 2019. As of January 31, 2021, the amount of the transaction price allocated to remaining performance obligations for contracts greater than one year was $1.1 billion. We expect to recognize 52% of the transaction price allocated to remaining performance obligations within the 12 months following January 31, 2021 in our consolidated statement of operations and comprehensive loss. Contract assets represent amounts for which we have recognized revenue, pursuant to our revenue recognition policy, for contracts that have not yet been invoiced to our customers where there is a remaining performance obligation, typically for multi-year arrangements. Total contract assets were $17.5 million and $13.4 million as of January 31, 2021 and 2020, of which $0.6 million and $0.9 million were noncurrent and included within “ Other assets—noncurrent ” on our consolidated balance sheets. The change in contract assets reflects the difference in timing between our satisfaction of remaining performance obligations and our contractual right to bill our customers. Contract liabilities consist of deferred revenue and include payments received in advance of performance under the contract. Such amounts are generally recognized as revenue over the contractual period. For the years ended January 31, 2021 , 2020 and 2019, we recognized revenue of $499.5 million , $374.8 million and $264.0 million that was included in the corresponding contract liability balance at the beginning of the periods presented. We receive payments from customers based upon contractual billing schedules. We record accounts receivable when the right to consideration becomes unconditional. Payment terms on invoiced amounts are typically 30 days. The following table represents a rollforward of our deferred contract acquisition and fulfillment costs: Year Ended January 31, (in thousands) 2021 2020 Deferred Contract Acquisition Costs Beginning balance $ 155,697 $ 115,985 Additions to deferred contract acquisition costs 185,970 99,382 Amortization of deferred contract acquisition costs (81,132) (58,192) Cumulative translation adjustment 1,984 (1,478) Ending balance $ 262,519 $ 155,697 Deferred Contract Fulfillment Costs Beginning balance $ 8,218 $ 3,432 Additions to deferred contract fulfillment costs 22,540 16,341 Amortization of deferred contract fulfillment costs (18,252) (11,555) Ending balance $ 12,506 $ 8,218 |
Deferred Contract Acquisition a
Deferred Contract Acquisition and Fulfillment Costs | 12 Months Ended |
Jan. 31, 2021 | |
Revenue from Contract with Customer [Abstract] | |
Deferred Contract Acquisition and Fulfillment Costs | Revenue and Performance Obligations Subscription revenue is recognized over time and accounted for approximately 95%, 94% and 95% of our revenue for the years ended January 31, 2021, 2020 and 2019. As of January 31, 2021, the amount of the transaction price allocated to remaining performance obligations for contracts greater than one year was $1.1 billion. We expect to recognize 52% of the transaction price allocated to remaining performance obligations within the 12 months following January 31, 2021 in our consolidated statement of operations and comprehensive loss. Contract assets represent amounts for which we have recognized revenue, pursuant to our revenue recognition policy, for contracts that have not yet been invoiced to our customers where there is a remaining performance obligation, typically for multi-year arrangements. Total contract assets were $17.5 million and $13.4 million as of January 31, 2021 and 2020, of which $0.6 million and $0.9 million were noncurrent and included within “ Other assets—noncurrent ” on our consolidated balance sheets. The change in contract assets reflects the difference in timing between our satisfaction of remaining performance obligations and our contractual right to bill our customers. Contract liabilities consist of deferred revenue and include payments received in advance of performance under the contract. Such amounts are generally recognized as revenue over the contractual period. For the years ended January 31, 2021 , 2020 and 2019, we recognized revenue of $499.5 million , $374.8 million and $264.0 million that was included in the corresponding contract liability balance at the beginning of the periods presented. We receive payments from customers based upon contractual billing schedules. We record accounts receivable when the right to consideration becomes unconditional. Payment terms on invoiced amounts are typically 30 days. The following table represents a rollforward of our deferred contract acquisition and fulfillment costs: Year Ended January 31, (in thousands) 2021 2020 Deferred Contract Acquisition Costs Beginning balance $ 155,697 $ 115,985 Additions to deferred contract acquisition costs 185,970 99,382 Amortization of deferred contract acquisition costs (81,132) (58,192) Cumulative translation adjustment 1,984 (1,478) Ending balance $ 262,519 $ 155,697 Deferred Contract Fulfillment Costs Beginning balance $ 8,218 $ 3,432 Additions to deferred contract fulfillment costs 22,540 16,341 Amortization of deferred contract fulfillment costs (18,252) (11,555) Ending balance $ 12,506 $ 8,218 |
Debt
Debt | 12 Months Ended |
Jan. 31, 2021 | |
Debt Disclosure [Abstract] | |
Debt | Debt Convertible Senior Notes In September 2018, we issued $575.0 million in aggregate principal amount of the 0.5% Convertible Senior Notes due in 2023 (“2023 Notes”), which included the initial purchasers’ exercise in full of their option to purchase an additional $75.0 million aggregate principal amount of the 2023 Notes. The net proceeds from the issuance of the 2023 Notes were $560.8 million after deducting the initial purchasers’ discounts and transaction costs. In January 2021, we issued $690.0 million in aggregate principal amount of the 0% Convertible Senior Notes due in 2024 (“2024 Notes,” and together with the 2023 Notes, the “Notes”), which included the initial purchasers’ exercise in full of their option to purchase an additional $90.0 million aggregate principal amount of the 2024 Notes. The net proceeds from the issuance of the 2024 Notes were $677.3 million after deducting the initial purchasers’ discounts and transaction costs. The Notes are senior unsecured obligations and rank senior in right of payment to any of our indebtedness that is expressly subordinated in right of payment to the Notes; equal in right of payment to any of our unsecured indebtedness then existing and future liabilities that are not so subordinated; effectively junior in right of payment to any of our secured indebtedness, to the extent of the value of the assets securing such indebtedness; and structurally junior to all indebtedness and other liabilities (including trade payables) of our subsidiaries. Upon conversion of the Notes, holders will receive cash, shares of our common stock or a combination of cash and shares of our common stock, at our election. The 2023 Notes are governed by an indenture dated September 18, 2018 (the “2018 Indenture”). The 2024 Notes are governed by an indenture dated January 15, 2021 (the “2021 Indenture,” and together with the 2018 Indenture, the “Indentures”). The Indentures are between us, as the issuer, and U.S. Bank National Association, as trustee. The Indentures do not contain any financial covenants or restrictions on the payments of dividends, the incurrence of indebtedness, or the issuance or repurchase of securities by us or any of our subsidiaries. The 2023 Notes mature on September 15, 2023, unless earlier repurchased or redeemed by us or earlier converted in accordance with their terms prior to the maturity date. Interest on the 2023 Notes is payable semi-annually in arrears on March 15 and September 15 of each year. The Notes are subject to additional interest in certain events of default. The 2024 Notes mature on January 15, 2024 unless earlier repurchased by us or earlier converted in accordance with their terms prior to the maturity date. Conversion terms The 2023 Notes have an initial conversion rate of 13.9860 shares of our common stock per $1,000 principal amount of the 2023 Notes, which is equal to an initial conversion price of approximately $71.50 per share of our common stock. The 2024 Notes have an initial conversion rate of 2.3796 shares of our common stock per $1,000 principal amount of the 2024 Notes, which is equal to an initial conversion price of approximately $420.24 per share of our common stock. The initial conversation rates are subject to adjustment in some events. Following certain corporate events that occur prior to the maturity date or, with respect to the 2023 Notes, following our issuance of a notice of redemption, we will increase the conversion rate for a holder who elects to convert its Notes in connection with such corporate event or during the related redemption period in certain circumstances. Additionally, upon the occurrence of a corporate event that constitutes a “fundamental change” as defined within the respective Indentures, holders of the Notes may require us to repurchase for cash all or a portion of their Notes at a purchase price equal to 100% of the principal amount of the Notes plus accrued and unpaid interest if any. No such corporate events have occurred as of January 31, 2021. Holders of the 2023 Notes may convert all or any portion of their 2023 Notes at any time on or after June 15, 2023, until the close of business on September 13, 2023. Prior to the close of business on the business day immediately preceding June 15, 2023, holders of the 2023 Notes may convert all or any portion of their 2023 Notes, in integral multiples of $1,000 principal amount, only under the following circumstances (the “2023 Notes conversion conditions”): • During any fiscal quarter commencing after the fiscal quarter ending on January 31, 2019 (and only during such fiscal quarter), if the last reported sale price of our common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding fiscal quarter is greater than or equal to 130% of the conversion price on each applicable trading day; • During the 5-business day period after any 10 consecutive trading day period (the “measurement period”) in which the trading price as defined in the 2018 Indenture per $1,000 principal amount of notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of our common stock and the conversion rate on each such trading day; • If we call any or all of the notes for redemption, at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date; or • Upon the occurrence of specified corporate events described in the 2018 Indenture. In the second, third and fourth quarter of the year ended January 31, 2021, the last reported sale price of our common stock for at least 20 trading days during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding fiscal quarter was greater than 130% of the conversion price. The 2023 Notes therefore became convertible on August 1, 2020 and continue to be convertible through January 31, 2021. Holders of the 2024 Notes may convert all or any portion of their 2024 Notes at any time on or after October 15, 2023, until the close of business on September 15, 2024. Prior to the close of business on the business day immediately preceding October 15, 2023, holders of the 2024 Notes may convert all or any portion of their 2024 Notes, in integral multiples of $1,000 principal amount, only under the following circumstances (the “2024 Notes conversion conditions”): • During any fiscal quarter commencing after the fiscal quarter ending on April 30, 2021 (and only during such fiscal quarter), if the last reported sale price of our common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding fiscal quarter is greater than or equal to 130% of the conversion price on each applicable trading day; • During the 5-business day period after any 10 consecutive trading day period (the “measurement period”) in which the trading price as defined in the 2021 Indenture per $1,000 principal amount of notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of our common stock and the conversion rate on each such trading day; or • Upon the occurrence of specified corporate events described in the 2021 Indenture. As of January 31, 2021, the 2024 Notes conversion conditions described above were not met and therefore the 2024 Notes are not yet convertible. Redemption terms We may redeem for cash or shares all or any portion of the 2023 Notes, at our option, at a redemption price equal to 100% of the principal amount of the notes to be redeemed, plus accrued and unpaid interest, beginning on or after September 20, 2021 if the last reported sale price of our common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding fiscal quarter is greater than or equal to 130% of the conversion price on each applicable trading day. We may not redeem the 2024 Notes prior to the maturity date. Repurchases of the 2023 Notes In connection with our issuance of the 2024 Notes, we used a portion of the proceeds to repurchase $460.0 million aggregate principal amount of the 2023 Notes in privately negotiated transactions for an aggregate consideration of $1.7 billion, consisting of $459.2 million in cash and 4.7 million shares of our common stock with a value of $1.2 billion, a non-cash financing activity. We recorded an extinguishment loss of $33.8 million as a result of the transaction. In our consolidated statement of cash flow, the cash paid to repurchase the 2023 Notes was bifurcated into two components: the portion of the repayment attributable to accreted interest related to debt discount is classified as cash outflows from operating activities, and the portion of the repayment attributable to the principal is classified as cash outflows from financing activities. In January 2021, certain holders of the 2023 Notes exercised their option to convert $23.9 million aggregate amount of the principal of the 2023 Notes to be settled in March 2021. As we are to settle the principal in cash, we reclassified $20.5 million of the carrying value to “Convertible senior notes—current.” Additionally, we reclassified $3.4 million, representing the difference between the aggregate principal and the carrying value, to mezzanine equity from permanent equity on our consolidated balance sheet as of January 31, 2021. Net Carrying Amounts of the Liability and Equity Components January 31, (in thousands) 2021 2020 2023 Notes (effective interest rate of 5.9%): Principal $ 575,000 $ 575,000 Less: extinguishment or conversion (460,000) — Unpaid principal 115,000 575,000 Less: unamortized debt discount (15,116) (101,461) Less: unamortized transaction costs (1,224) (8,218) Net carrying value of current and noncurrent liability component $ 98,660 $ 465,321 Proceeds allocated to the conversion option (debt discount) $ 134,667 $ 134,667 Less: extinguishment or conversion (31,933) — Less: transaction costs (3,336) (3,336) Net carrying value of mezzanine and permanent equity component $ 99,398 $ 131,331 Excess of if-converted value over principal $ 259,578 2024 Notes (effective interest rate of 3.8%): Principal $ 690,000 Less: unamortized debt discount (63,619) Less: unamortized transaction costs (11,353) Net carrying value of noncurrent liability component $ 615,028 Proceeds allocated to the conversion option (debt discount) $ 64,453 Less: transaction costs (1,185) Net carrying value of permanent equity component $ 63,268 Excess of if-converted value over principal $ — Interest expense recognized related to the Notes was as follows: Year Ended January 31, (in thousands) 2021 2020 2019 Contractual interest expense $ 2,773 $ 2,865 $ 1,071 Amortization of debt discount 25,828 24,411 8,795 Amortization of transaction costs 2,173 1,978 712 Total $ 30,774 $ 29,254 $ 10,578 Capped Calls To minimize the potential economic dilution to our common stock upon conversion of the Notes, we entered into privately-negotiated capped call transactions ("Capped Calls") with certain counterparties. The capped call transactions were as follows: (in thousands, except per share amounts) 2023 Notes 2024 Notes Aggregate cost of capped calls $ 67,563 $ 31,395 Initial strike price per share (1) $ 71.50 $ 420.24 Initial cap price per share (1) $ 110.00 $ 525.30 Shares of our common stock covered by the capped calls (1) 8,042 1,642 (1) Subject to adjustments for certain events, such as merger events and tender offers, and anti-dilution adjustments Impact on Loss Per Share In periods when we have net income, the shares of our common stock subject to the Notes outstanding during the period is included in our diluted earnings per share under the if-converted method, as share settlement is presumed as of the fourth quarter of 2021. In prior periods, cash settlement was presumed and shares subject to the Notes would have been included under the treasury stock method. Capped Calls are excluded from the calculation of diluted earnings per share, as they would be antidilutive. However, upon conversion, there will be no economic dilution from the Notes unless the market price of our common stock exceeds the cap prices listed above in the Capped Calls section, as exercise of the Capped Calls offsets any dilution from the Notes from the conversion price up to the cap price. As of January 31, 2021, the market price of a share of our common stock exceeded the $110.00 cap price associated with the 2023 Notes but not the $525.30 cap price associated with the 2024 Notes; therefore, the 2023 Notes would have caused economic dilution if converted. Revolving Credit Facility In January 2021, we entered into a credit agreement with a syndicate of banks. The credit agreement extended a senior secured revolving credit facility to us in an aggregate principal amount of $500.0 million, which amount may be increased by an additional $250.0 million subject to the terms of the credit agreement. We may use the proceeds of future borrowings under the credit facility to finance working capital, capital expenditures and for other general corporate purposes, including permitted acquisitions. The facility matures in January 2026 and requires us to comply with customary affirmative and negative covenants. We were in compliance with all covenants as of January 31, 2021. As of January 31, 2021, there were no outstanding borrowings under the revolving credit facility. The facility is subject to customary fees for loan facilities of this type, including ongoing commitment fees at a rate between 0.25% and 0.30% per annum on the daily undrawn balance. |
Leases
Leases | 12 Months Ended |
Jan. 31, 2021 | |
Leases [Abstract] | |
Leases | Leases We lease offices under noncancelable operating lease agreements that expire at various dates through end of February 2032. As of January 31, 2021, we had no finance leases. Some of our operating leases contain escalation provisions for adjustments in the consumer price index. The following table is a summary of our lease costs: Year Ended January 31, (in thousands) 2021 2020 Operating lease cost $ 34,034 $ 26,490 Short-term lease cost 793 837 Total lease cost $ 34,827 $ 27,327 Rent expense under operating leases was $19.8 million during the year ended January 31, 2019. Future lease payments under noncancelable operating leases as of January 31, 2021, were as follows: Fiscal Period: Amount (in thousands) 2022 $ 40,603 2023 42,180 2024 39,352 2025 31,034 2026 20,254 Thereafter 53,682 Total undiscounted cash flows $ 227,105 Less: imputed interest (28,430) Present value of lease liabilities $ 198,675 The weighted average remaining lease term as of January 31, 2021 and 2020 were 6.6 years and 7.7 years. The discount rate for operating leases as of January 31, 2021 and 2020 were 4.3% and 4.4%. |
Commitments and Contingencies
Commitments and Contingencies | 12 Months Ended |
Jan. 31, 2021 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | Commitments and Contingencies As of January 31, 2021, we had unused letters of credit outstanding associated with our various operating leases totaling $7.4 million. We have entered into certain noncancelable contractual arrangements that require future purchases of goods and services. These arrangements primarily relate to cloud infrastructure support and sales and marketing activities. As of January 31, 2021, our future noncancelable minimum payments due under these contractual obligations with a remaining term of more than one year were as follows: Fiscal Period: Amount (in thousands) 2022 $ 17,902 2023 19,410 2024 13,638 2025 6,537 2026 5,023 Thereafter 3,145 Total $ 65,655 Indemnification We enter into indemnification provisions under our agreements with customers and other companies in the ordinary course of business, including business partners, contractors and parties performing our research and development. Pursuant to these arrangements, we agree to indemnify and defend the indemnified party for certain claims and related losses suffered or incurred by the indemnified party from actual or threatened third-party claims because of our activities. The duration of these indemnification agreements is generally perpetual. The maximum potential amount of future payments we could be required to make under these indemnification clauses or agreements is not determinable. Historically, we have not incurred material costs to defend lawsuits or settle claims related to these indemnification agreements. As a result, we believe the fair value of these indemnification agreements is not material as of January 31, 2021 and 2020 . We maintain commercial general liability insurance and product liability insurance to offset certain of our potential liabilities under these indemnification agreements. We have entered into indemnification agreements with each of our directors, executive officers and certain other officers. These agreements require us to indemnify such individuals, to the fullest extent permitted by Delaware law, for certain liabilities to which they may become subject as a result of their affiliation with us. Claims and Litigation From time to time, we may be subject to legal proceedings, claims and litigation made against us in the ordinary course of business. We believe the final outcome of these matters will not have a material adverse effect on our business, consolidated financial position, results of operations or cash flows. |
Stockholders' Equity
Stockholders' Equity | 12 Months Ended |
Jan. 31, 2021 | |
Equity [Abstract] | |
Stockholders' Equity | Stockholders' Equity Redeemable Convertible Preferred Stock Prior to the IPO we issued Series A, Series A-1, Series B, Series B-1, Series C, Series D, Series E, and Series F redeemable convertible preferred stock. Upon completion of the IPO, all 100.2 million shares of our convertible preferred stock automatically converted into an aggregate of 100.4 million shares of our common stock. Common Stock Reserved for Future Issuance We have reserved the following shares of common stock, on an as-if converted basis, for future issuance as follows: January 31, (in thousands) 2021 2020 RSUs outstanding 10,962 14,246 Options issued and outstanding 4,798 6,882 Remaining shares available for future issuance under the Equity Incentive Plans 32,901 24,726 Remaining shares available for future issuance under the ESPP 6,329 4,985 Total shares of common stock reserved 54,990 50,839 Equity Incentive Plans We maintain three stock-based compensation plans: the 2018 Equity Incentive Plan (the “2018 Plan”), the Amended and Restated 2011 Equity Incentive Plan (the “2011 Plan”) and the Amended and Restated 2003 Stock Plan (the “2003 Plan”). Our board of directors adopted, and our stockholders approved, the 2018 Plan during the year ended January 31, 2019. The 2018 Plan went into effect in April 2018, upon the effectiveness of our IPO Registration Statement. The 2018 Plan serves as a successor to the 2011 Plan and 2003 Plan and provides for the grant of stock-based awards to our employees, directors and consultants. Shares available for grant under the 2011 Plan that were reserved but not issued as of the effective date of the 2018 Plan were added to the reserves of the 2018 Plan. No additional awards under the 2011 Plan or 2003 Plan have been made since the effective date of the 2018 Plan. Outstanding awards under these two plans continue to be subject to the terms and conditions of the respective plans. Additionally, any shares subject to outstanding awards originally granted under the 2011 Plan that: (i) expire or terminate for any reason prior to exercise or settlement; (ii) are forfeited because of the failure to meet a contingency or condition required to vest such shares or otherwise returned to DocuSign, Inc.; or (iii) are reacquired, withheld (or not issued) to satisfy a tax withholding obligation in connection with an award or to satisfy the purchase price or exercise price of a stock award are added to the reserves of the 2018 Plan. The 2018 Plan permits the granting of incentive stock options, nonstatutory stock options, stock appreciation rights, restricted stock awards, restricted stock unit awards, performance stock awards, performance cash awards and other stock awards. RSUs granted under the 2018 Plan generally vest over a four-year period, either quarterly or with 25% vesting at the end of one year and the remainder quarterly thereafter. Additionally, the Company grants performance-based and market-based RSUs to its executives on an annual basis. Shares available for grant under the 2018 Plan for the year ended January 31, 2021 was as follows: (in thousands) Year Ended Available at beginning of fiscal year 24,726 Awards authorized 9,063 Shares granted (4,032) Shares cancelled/expired 886 Shares withheld for taxes 2,258 Available at end of fiscal year 32,901 The 2018 Plan provides that the number of shares reserved will automatically increase on the first day of each fiscal year, beginning on February 1, 2019, and ending on February 1, 2028, by 5% of the total number of shares of our capital stock outstanding on the immediately preceding January 31st (or such lesser number of shares as our board of directors or a committee of our board of directors may approve). The most recent automatic increase of 9.6 million shares occurre d o n February 1, 2021. RSUs The majority of RSUs granted after January 31, 2018 vest upon the satisfaction of a service-based vesting condition. From time to time, we may also grant RSUs that are subject to either a performance-based or market-based vesting condition. The performance-based conditions will be satisfied upon satisfaction of certain financial performance targets. The market-based conditions will be satisfied if certain milestones based on our common stock price or relative total shareholder return are met. The weighted-average grant date fair value for RSUs granted during the years ended January 31, 2021, 2020 and 2019 was $144.80, $56.05 and $53.77 per share. The total grant date fair value of RSUs vested during the years ended January 31, 2021, 2020 and 2019 was $282.3 million, $223.0 million and $260.8 million. RSU activity for the year ended January 31, 2021 was as follows: (in thousands, except per share data) Number of Units Weighted-Average Grant Date Fair Value Unvested at January 31, 2020 13,859 $ 46.28 Granted 4,022 144.80 Vested (6,318) 44.67 Canceled (977) 53.81 Unvested at January 31, 2021 10,586 $ 83.98 As of January 31, 2021, our total unrecognized compensation cost related to RSUs was $680.7 million. We expect to recognize this expense over the remaining weighted-average period of approximately 2.2 years. Stock Options There were no options granted during the years ended January 31, 2021, 2020 and 2019 . Option activity for the year ended January 31, 2021 was as follows: (in thousands, except per share data and years) Number of Options Weighted-Average Exercise Price Per Share Weighted-Average Remaining Contractual Term (Years) Aggregate Intrinsic Value Outstanding at January 31, 2020 6,882 $ 14.39 5.38 $ 441,247 Issued as consideration for acquisition 9 22.22 Exercised (2,072) 11.71 Canceled/expired (21) 18.09 Outstanding at January 31, 2021 4,798 $ 15.55 5.03 $ 1,042,879 Vested and expected to vest at January 31, 2021 4,798 $ 15.55 5.03 $ 1,042,801 Exercisable at January 31, 2021 4,761 $ 15.54 5.02 $ 1,034,740 As of January 31, 2021, our total unrecognized compensation cost related to stock option grants was $0.2 million. We expect to recognize this expense over the remaining weighted-average period of approximately 0.2 years. The aggregate intrinsic value of options exercised during the years ended January 31, 2021, 2020 and 2019 was $302.4 million, $325.7 million and $171.6 million. The total grant date fair value of options vested during the years ended January 31, 2021, 2020 and 2019 was $7.5 million, $10.5 million and $25.8 million. 2018 Employee Stock Purchase Plan During the year ended January 31, 2019, our board of directors adopted, and our stockholders approved the ESPP. In April 2018, the ESPP went into effect upon the effectiveness of our IPO Registration Statement. The ESPP allows eligible employees to purchase shares of our common stock at a discounted price by accumulating funds, normally through payroll deductions, of up to 15% of their earnings. The purchase price for common stock under the ESPP is equal to 85% of the fair market value of our common stock on the first or last day of the offering period, whichever is lower. The ESPP provides for separate six-month offering periods that begin in the first and third quarter of each year. We calculated the fair value of the ESPP purchase right using the Black-Scholes option-pricing model, based on the following assumptions: Year Ended January 31, 2021 2020 2019 Risk-free interest rate 0.11% - 0.17% 1.92% - 2.52 % 2.33 % Expected dividend yield — % — % — % Expected life of purchase right (in years) 0.5 0.5 0.5 Expected volatility 47% - 58% 39% - 52 % 40 % Weighted-average grant date fair value per share $90.15 - $221.20 $ 14.88 - $18.56 $ 14.24 The expected term for the ESPP purchase rights is based on the duration of the offering period. Estimated volatility for ESPP purchase rights is based on the historical volatility of our common stock price. The interest rate is derived from government bonds with a similar term to the ESPP purchase right granted. We have not declared, nor do we expect to declare dividends. Compensation expense related to the ESPP was $12.6 million, $8.9 million and $2.9 million for the years ended January 31, 2021, 2020 and 2019. The number of shares reserved under the ESPP will automatically increase on the first day of each fiscal year, starting on February 1, 2019 and continuing through February 1, 2028, in an amount equal to the lesser of (i) 1% of the total number of shares of our common stock outstanding on January 31 of the preceding fiscal year, (ii) 3.8 million shares, or (iii) a lesser number of shares determined by our board of directors. As of January 31, 2021, 6.3 million shares of common stock were reserved for issuance under the ESPP. |
Net Loss per Share Attributable
Net Loss per Share Attributable to Common Stockholders | 12 Months Ended |
Jan. 31, 2021 | |
Earnings Per Share [Abstract] | |
Net Loss per Share Attributable to Common Stockholders | Net Loss per Share Attributable to Common Stockholders The following table presents the calculation of basic and diluted net loss per share attributable to common stockholders for periods presented: Year Ended January 31, (in thousands, except per share data) 2021 2020 2019 Numerator: Net loss $ (243,267) $ (208,359) $ (426,458) Less: preferred stock accretion — — (353) Net loss attributable to common stockholders $ (243,267) $ (208,359) $ (426,811) Denominator: Weighted-average common shares outstanding 185,760 176,704 135,163 Net loss per share attributable to common stockholders: Basic and diluted $ (1.31) $ (1.18) $ (3.16) Outstanding potentially dilutive securities that were excluded from the diluted per share calculations because they would have been antidilutive are as follows: January 31, (in thousands) 2021 2020 2019 RSUs 10,586 13,555 16,568 Stock options 4,798 6,882 13,648 ESPP 130 274 295 Convertible senior notes 3,250 788 — Total antidilutive securities 18,764 21,499 30,511 |
Employee Benefit Plan
Employee Benefit Plan | 12 Months Ended |
Jan. 31, 2021 | |
Postemployment Benefits [Abstract] | |
Employee Benefit Plan | Employee Benefit PlanWe have a qualified defined contribution plan under Section 401(k) of the Internal Revenue Code (the “Plan”). This Plan covers substantially all employees who meet minimum age and service requirements and allows participants to defer a portion of their annual compensation on a pre-tax basis. In the fourth quarter of fiscal 2019, we began to match 50% of each participant’s contribution up to a maximum of 6% of the participant’s base salary and commissions paid during the period. During the year ended January 31, 2021, 2020 and 2019, we recognized expenses of $18.9 million, $11.0 million and $1.7 million related to matching contributions. |
Income Taxes
Income Taxes | 12 Months Ended |
Jan. 31, 2021 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | Income Taxes The domestic and foreign components of pre-tax loss were as follows: Year Ended January 31, (in thousands) 2021 2020 2019 U.S. $ (240,175) $ (228,476) $ (460,627) International 10,683 24,920 32,419 Loss before income taxes $ (229,492) $ (203,556) $ (428,208) The components of our income tax provision (benefit) were as follows: Year Ended January 31, (in thousands) 2021 2020 2019 Current Federal $ (35) $ — $ — State 269 239 413 Foreign 15,951 3,277 2,838 Total current 16,185 3,516 3,251 Deferred Federal (243) — (7,083) State 5 (43) (2) Foreign (2,172) 1,330 2,084 Total deferred (2,410) 1,287 (5,001) Provision for (benefit from) income taxes $ 13,775 $ 4,803 $ (1,750) The reconciliation of the statutory federal income tax rate to our effective tax rate was as follows: Year Ended January 31, (in percentage) 2021 2020 2019 U.S statutory rate 21.0 % 21.0 % 21.0 % State taxes 2.7 3.5 3.1 Foreign tax rate differential 0.1 0.5 0.3 Increase (decrease) unrecognized tax benefit (5.6) — — Stock-based compensation 87.1 47.2 17.5 Change in valuation allowance (118.4) (80.3) (43.6) Research and development credits 9.1 8.2 4.0 Other deferred adjustment (1.1) — — Other (0.9) (2.4) (1.9) Effective tax rate (6.0) % (2.3) % 0.4 % The significant components of net deferred tax balances were as follows: January 31, (in thousands) 2021 2020 Deferred tax assets Net operating loss carryforwards $ 682,872 $ 423,379 Accruals and reserves 14,744 5,668 Stock-based compensation 30,377 33,405 Operating lease liability 36,148 40,495 Research and development credits 60,386 39,480 Other 14,398 7,536 Total deferred tax assets 838,925 549,963 Less: Valuation allowance (723,767) (445,746) Deferred tax assets, net of valuation allowance 115,158 104,217 Deferred tax liabilities Operating lease right-of-use asset (27,654) (32,736) Deferred contract acquisition costs (61,432) (36,567) Convertible debt (18,854) (24,737) Acquired intangibles (11,939) (13,493) Other (893) (1,457) Total deferred tax liabilities (120,772) (108,990) Net deferred tax liabilities $ (5,614) $ (4,773) We intend to invest substantially all of our foreign subsidiary earnings, as well as our capital in our foreign subsidiaries, indefinitely outside of the U.S. in those jurisdictions in which we would incur significant, additional costs upon repatriation of such amounts. Therefore, no deferred tax liabilities for foreign withholding taxes have been recorded relating to the earnings of our foreign subsidiaries. In the years ended January 31, 2021, 2020 and 2019, total stock-based compensation expense was $286.9 million, $206.4 million and $411.0 million. Recognized tax benefits on total stock-based compensation expense, which are reflected in the "Provision for (benefit from) income taxes" in the consolidated statements of operations and comprehensive loss, were $2.2 million, $1.0 million and $1.7 million in the years ended January 31, 2021, 2020 and 2019. As of January 31, 2021, we had accumulated net operating loss carryforwards of $2.8 billion for federal and $1.3 billion for state. Of the federal net operating losses, $2.3 billion is carried forward indefinitely, but is limited to 80% of taxable income. The remaining federal and state net operating loss carryforwards will begin to expire in 2025 and 2021. As of January 31, 2021, we also had total foreign net operating loss carryforwards of $38.0 million, which do not expire under local law. As of January 31, 2021, we had accumulated U.S. research tax credits of $63.9 million for federal and $17.0 million for state. The U.S. federal research tax credits will begin to expire in 2033. The U.S. state research tax credits do not expire. Available net operating losses may be subject to annual limitations due to ownership change limitations provided by the Internal Revenue Code, as amended (the "Code"), and similar state provisions. Under Section 382 of the Code, substantial changes in our ownership and the ownership of acquired companies may limit the amount of net operating loss carryforwards that are available to offset taxable income. Our ability to carry forward our federal and state net operating losses is limited due to an ownership change that occurred in a prior fiscal year. This limitation has been accounted for in calculating the available net operating loss carryforwards. The foreign jurisdictions in which we operate may have similar provisions that may limit our ability to use net operating loss carryforwards incurred by entities that we have acquired. Additional limitations on the use of these tax attributes could occur in the event of possible disputes arising in examination from various taxing authorities. A reconciliation of the beginning and ending balance of total unrecognized tax benefits was as follows: January 31, (in thousands) 2021 2020 Unrecognized tax benefits balance at February 1 $ 12,885 $ 9,733 Gross increase for tax positions of prior years 2,012 90 Gross decrease for tax positions of prior years — (94) Gross increase for tax positions of current year 18,882 3,156 Unrecognized tax benefits balance at January 31 $ 33,779 $ 12,885 As of January 31, 2021, the total amount of unrecognized tax benefits that would affect our effective tax rate, if recognized, would have been $15.9 million. A significant portion of the unrecognized tax benefit was recorded as a reduction in our gross deferred tax assets, offset by a reduction in our valuation allowance. We have net uncertain tax positions of $16.7 million, $3.3 million and $2.9 million included in other liabilities on our consolidated balance sheet as of January 31, 2021, 2020 and 2019. We do not expect our gross unrecognized tax benefit to change significantly within the next 12 months. We recognize interest and penalties related to uncertain tax positions in provision for income taxes. As of January 31, 2021, accrued interest or penalties was $0.8 million. Our tax years from inception in 2003 through January 31, 2021, remain subject to examination by the U.S. and California, as well as various other jurisdictions. We are under examination by the Israeli Tax Authorities for the calendar years 2016 through 2019. We recognize valuation allowances on deferred tax assets if it is more likely than not that some or all the deferred tax assets will not be realized. Due to our history of losses in the U.S., the net cumulative U.S. deferred tax assets have been fully offset by a valuation allowance. The valuation allowance increased by $278.0 million in the year ended January 31, 2021 and by $163.6 million in the year ended January 31, 2020. The following table represents the rollforward of our valuation allowance: Year Ended January 31, (in thousands) 2021 2020 2019 Beginning balance $ 445,746 $ 282,141 $ 119,153 Valuation allowance charged to income tax provision 269,135 163,605 201,646 Valuation allowance from acquisitions 9,354 — — Convertible senior notes settled 14,985 — — Convertible senior notes issued (15,453) — (31,594) Acquisition of SpringCM — — (7,064) Ending balance $ 723,767 $ 445,746 $ 282,141 |
Geographic Information
Geographic Information | 12 Months Ended |
Jan. 31, 2021 | |
Segment Reporting [Abstract] | |
Geographic Information | Geographic Information We operate in one operating segment and one reportable segment as we only report financial information on an aggregate and consolidated basis to the Chief Executive Officer, who is our CODM. Revenue by geography is based on the address of the customer as specified in our master subscription agreement. Revenue by geographic area was as follows: Year Ended January 31, (in thousands) 2021 2020 2019 U.S. $ 1,166,004 $ 802,480 $ 581,011 International 287,043 171,491 119,958 Total revenue $ 1,453,047 $ 973,971 $ 700,969 No single country other than the U.S. had revenue greater than 10% of total revenue in the years ended January 31, 2021, 2020 and 2019. Our long-lived assets by geographic area, which consist of property and equipment, net and operating lease right-of-use assets were as follows: January 31, (in thousands) 2021 2020 U.S. $ 221,549 $ 182,288 Ireland 66,670 66,925 All other countries 36,172 28,913 Total long-lived assets $ 324,391 $ 278,126 |
Subsequent Events
Subsequent Events | 12 Months Ended |
Jan. 31, 2021 | |
Subsequent Events [Abstract] | |
Subsequent Events | Subsequent Events Between February 1, 2021 and March 30, 2021, we received conversion notices on our 2023 Notes for $12.8 million in aggregate principal amount, for which we elected to settle the principal amount in cash during the three months ended April 30, 2021 and for $6.6 million in aggregate principal amount, for which we elected to settle the principal amount in cash in the three months ended July 31, 2021. During that period, we also settled the $23.9 million of 2023 Notes for which conversion was elected prior to January 31, 2021, for aggregate consideration of $72.3 million, consisting of $23.9 million in cash and 0.2 million shares of our common stock with a value of $48.4 million. |
Summary of Significant Accoun_2
Summary of Significant Accounting Policies (Policies) | 12 Months Ended |
Jan. 31, 2021 | |
Accounting Policies [Abstract] | |
Consolidation | Basis of Presentation and Principles of ConsolidationOur consolidated financial statements include those of DocuSign, Inc. and our subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. |
Basis of Accounting | Basis of Presentation and Principles of Consolidation Our consolidated financial statements include those of DocuSign, Inc. and our subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. The accompanying consolidated financial statements have been prepared in accordance with United States (“U.S.”) generally accepted accounting principles (“GAAP”). Our fiscal year ends on January 31. References to fiscal 2021, for example, are to the fiscal year ended January 31, 2021. Certain prior year amounts have been reclassified to conform to current year presentation. These amounts were not material to any of the periods presented. |
Use of Estimates | Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions in the consolidated financial statements and notes thereto. Significant items subject to such estimates and assumptions made by management include, but are not limited to, the determination of: • the fair value of assets acquired and liabilities assumed in business combinations; • the average period of benefit associated with deferred contract acquisition costs and fulfillment costs; • the valuation of strategic investments; • the fair value of certain stock awards issued; • the f air value of the liability and equity components of convertible notes; • the useful life and recoverability of long-lived assets; • the discount rate used for operating leases; and • the recognition, measurement and valuation of deferred income taxes. The World Health Organization declared in March 2020 that the outbreak of the coronavirus disease named COVID-19 constitutes a global pandemic. We have undertaken measures to protect our employees, partners and customers. There can be no assurance that these measures will be effective, however, or that we can adopt them without adversely affecting our business operations. In addition, the COVID-19 pandemic has created and may continue to create significant uncertainty in global financial markets, which may decrease technology spending, depress demand for our products and harm our business and results of operations. As of the date of issuance of the financial statements, we are not aware of any specific event or circumstance that would require us to update our estimates, judgments or revise the carrying value of our assets or liabilities. These estimates may change, as new events occur and additional information is obtained, and are recognized in the consolidated financial statements as soon as they become known. Actual results could differ from those estimates and any such differences may be material to our financial statements. |
Concentration of Credit Risk | Concentration of Credit Risk Our financial instruments that are exposed to concentrations of credit risk consist primarily of cash, cash equivalents, marketable securities and accounts receivable. Although we deposit our cash with multiple financial institutions, the deposits, at times, may exceed federally insured limits. We have not experienced any losses on our deposits of cash and cash equivalents. Cash equivalents consist of money market funds which are invested through financial institutions in the U.S. Management believes that the institutions are financially stable and, accordingly, minimal credit risk exists. No customer individually accounted for more than 10% of our revenues in the years ended January 31, 2021, 2020 and 2019 or for more than 10% of our accounts receivable as of January 31, 2021 and 2020. We perform ongoing credit |
Revenue Recognition | Revenue Recognition We recognize revenue when a customer obtains control of promised services. We apply significant judgment in identifying and evaluating any terms and conditions in contracts which may impact revenue recognition. The amount of revenue recognized reflects the consideration that we expect to be entitled to receive in exchange for these services. To achieve the core principle of this standard, we apply the following steps: 1. Identification of the contract, or contracts, with the customer We consider the terms and conditions of the contract and our customary business practices in identifying our contracts under ASC 606. We determine we have a contract with a customer when the contract is approved, we can identify each party’s rights regarding the services to be transferred, we can identify the payment terms for the services, we have determined the customer has the ability and intent to pay and the contract has commercial substance. At contract inception we evaluate whether two or more contracts should be combined and accounted for as a single contract and whether the combined or single contract includes more than one performance obligation. We apply judgment in determining the customer’s ability and intent to pay, which is based on a variety of factors, including the customer’s historical payment experience or, in the case of a new customer, credit and financial information pertaining to the customer. 2. Identification of the performance obligations in the contract Performance obligations promised in a contract are identified based on the services and the products that will be transferred to the customer that are both capable of being distinct, whereby the customer can benefit from the service either on its own or together with other resources that are readily available from third parties or from us, and are distinct in the context of the contract, whereby the transfer of the services and the products is separately identifiable from other promises in the contract. Our performance obligations consist of (i) subscription services, (ii) professional services, (iii) on-premises solutions, and (iv) maintenance and support for on-premises solutions. 3. Determination of the transaction price The transaction price is determined based on the consideration to which we expect to be entitled in exchange for transferring services to the customer. Variable consideration is included in the transaction price if, in our judgment, it is probable that a significant future reversal of cumulative revenue under the contract will not occur. None of our contracts contain a significant financing component. 4. Allocation of the transaction price to the performance obligation in the contract If the contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. Contracts that contain multiple performance obligations require an allocation of the transaction price to each performance obligation based on a relative standalone selling price ("SSP"). 5. Recognition of the revenue when, or as, we satisfy a performance obligation Revenue is recognized at the time the related performance obligation is satisfied by transferring the control of the promised service to a customer. Revenue is recognized as control of the service is transferred to the customer, in an amount that reflects the consideration that we expect to receive in exchange for those services. We generate all our revenue from contracts with customers. Subscription Revenue We generate revenue primarily from sales of subscriptions to access our software suite and related subscriptions of our customers. Our subscription revenue is driven by our go-to-market model, which includes a combination of direct sales, partner-assisted sales and web-based self-service purchasing. Subscription arrangements with customers do not provide the customer with the right to take possession of our software operating our software suite at any time. Instead, customers are granted continuous access to our software suite over the contractual period. A time-elapsed method is used to measure progress because we transfer control evenly over the contractual period. Accordingly, the fixed consideration related to subscription revenue is generally recognized on a straight-line basis over the contract term beginning on the date access to our software suite is provided. Professional Services and Other Revenue Professional services and other revenue consists of fees associated with consulting and training services from assisting customers in implementing and expanding the use of our software suite. These services are generally distinct from subscription services. Professional services do not result in significant customization of the subscription service. Revenue from professional services provided on a time and materials basis is recognized as the services are performed. Other revenue includes amounts derived from the sale of our on-premises solutions, which are recognized upon passage of control, which occurs upon shipment of the product. The maintenance and support on the on-premises solutions is a stand-ready obligation to perform this service over the term of the arrangement and, as a result, is accounted for ratably over the term of the arrangement. Contracts with Multiple Performance Obligations Most of our contracts with customers contain multiple performance obligations that are distinct and accounted for separately. The transaction price is allocated to the separate performance obligations on a relative SSP basis. We determine SSP for our performance obligations based on our observable inputs, such as standalone sales and historical contract pricing. SSP is consistent with our overall pricing objectives, taking into consideration the type of subscription services and professional and other services. Variable Consideration Revenue from sales is recorded at the net sales price, which is the transaction price, and includes estimates of variable consideration. The amount of variable consideration that is included in the transaction price is constrained and is included in the net sales price only to the extent that it is probable that a significant reversal in the amount of the cumulative revenue will not occur when the uncertainty is resolved. If our services do not meet certain service level commitments, our customers are entitled to receive service credits, and in certain cases, refunds, each representing a form of variable consideration. We have historically not experienced any significant incidents affecting the defined levels of reliability and performance as required by our subscription contracts. Accordingly, the amount of any estimated refunds related to these agreements in the consolidated financial statements is not material during the periods presented. Deferred Contract Fulfillment Costs We capitalize third-party costs to fulfill contracts with a customer in “Prepaid expenses and other current assets” and “Other assets—noncurrent” on our consolidated balance sheets. We amortize these costs on a straight-line basis consistent with the ratable revenue recognition of the performance obligations in the associated contracts. Cost of Revenue “Subscription” cost of revenue primarily consists of personnel and related costs to support our software suite, amortization expense associated with capitalized internally-developed software and technology-related intangible assets, property and equipment depreciation, allocated overhead expenses, merchant processing fees and server hosting costs. “Professional services and other” cost of revenue consists primarily of personnel costs for our professional services delivery team, travel-related costs and allocated overhead. |
Deferred Contract Acquisition Costs | Deferred Contract Acquisition Costs We capitalize sales commissions, certain parts of the company bonus and associated payroll taxes paid to internal sales personnel that are incremental to the acquisition of customer contracts as deferred contract acquisition costs in "Prepaid expenses and other current assets" and "Deferred contract acquisition costs—noncurrent" on our consolidated balance sheets. We determine whether costs should be deferred based on our sales compensation plans, if the commissions are in fact incremental and would not have occurred absent the customer contract. These deferred commissions are amortized on a straight-line basis over the periods of benefit, commensurate with the pattern of revenue recognition. Commissions paid for renewal of a subscription contract are not considered commensurate with the commissions paid for the acquisition of the initial subscription contract given the substantive difference in commission rates between new and renewal contracts. The period of benefit for commissions paid for the acquisition of the initial subscription contract, of five years, is determined by taking into consideration our initial estimated customer life and the technological life of our software suite and related significant features. The period of benefit for renewal subscription contracts, of two years, is determined by considering the average contractual term for renewal contracts. Commissions paid on professional services contracts are amortized over the period of benefit, being the period the associated revenue is earned as the commissions paid on new and renewal professional services contracts are commensurate with each other. Amortization of deferred contract acquisition costs is primarily included in the “Sales and marketing” expense in the consolidated statements of operations and comprehensive loss. We periodically review these deferred costs to determine whether events or changes in circumstances have occurred that could impact the period of benefit of these deferred contract acquisition costs. There were no material impairment losses recorded during the periods presented. |
Advertising | Advertising Advertising costs are expensed as incurred and are included in “Sales and marketing” expense in our consolidated statements of operations and comprehensive loss. Advertising expense was $78.6 million, $41.6 million and $34.1 million in the years ended January 31, 2021, 2020 and 2019. |
Research and Development | Research and Development Research and development costs are expensed as incurred and consist primarily of personnel costs, including salaries, bonuses and benefits, and stock-based compensation. |
Stock-Based Compensation | Stock-Based Compensation Compensation cost for stock-based awards issued to employees, including stock options, employee stock purchase plan (“ESPP”) purchase rights and restricted stock units (“RSUs”), is measured at fair value on the date of grant and recognized over the service period, generally on a straight-line basis. The fair value of stock options and ESPP purchase rights is estimated on the date of grant using a Black-Scholes option-pricing model. The fair value of RSUs is estimated on the date of grant based on the fair value of our underlying common stock. From time to time, we grant RSUs that also include performance-based or market-based conditions. For RSUs granted with a market condition, we use a lattice model simulation analysis to value the RSUs. Compensation expense for RSUs granted prior to January 31, 2018, is recognized on a graded basis over the requisite service period. Such RSUs contain a performance condition in the form of a specified liquidity event which was satisfied upon the effectiveness of our registration statement on Form S-1 (“IPO Registration Statement”) on April 26, 2018. On that date we recorded a cumulative stock-based compensation expense of $262.8 million using the accelerated attribution method for all the RSUs, for which the service condition has been fully satisfied as of April 26, 2018. The remaining unrecognized stock-based compensation expense related to the RSUs will be recorded over their remaining requisite service periods. RSUs granted after January 31, 2018, generally vest only on the satisfaction of service-based condition. Compensation expense for RSUs granted with a market or a performance condition is recognized on a graded vesting basis over the requisite service period. The amount of compensation expense related to the RSUs granted with a performance condition is determined after assessing the probability of achieving requisite performance criteria. We recognize compensation expense related to shares issued pursuant to the 2018 ESPP on a straight-line basis over the offering period of six months. Compensation expense is recognized net of forfeitures that are estimated at the time of grant and revised in subsequent periods if actual forfeitures differ from those estimates. We capitalize stock-based compensation costs incurred as a result of qualifying internally-developed software development activities. We may elect to issue shares on the settlement dates net of the statutory tax withholding requirements to be paid by us on behalf of our employees. In these instances, we record the liability for withholding amounts to be paid by us as |
Income Taxes | Income TaxesWe use the asset and liability method of accounting for income taxes. Under this method, income tax expense is recognized for the amount of taxes payable or refundable for the current year. In addition, deferred tax assets and liabilities are recognized for expected future tax consequences of temporary differences between the financial reporting and tax basis of assets and liabilities, and for operating losses and tax credit carryforwards. We record a valuation allowance to reduce our deferred tax assets to an amount for which realization is more likely than not. |
Foreign Currency | Foreign Currency The functional currency of our foreign entities and branches is generally the local currency. Monetary assets and liabilities and transactions denominated in currencies other than an entity's functional currency are remeasured into its functional currency using current exchange rates, whereas nonmonetary assets and liabilities are remeasured using historical exchange rates. We recognize gains and losses from such remeasurements within “Interest income and other income, net” in the consolidated statements of operations and comprehensive loss in the period of occurrence. We recorded a foreign currency transaction gain of $1.9 million for the year ended January 31, 2021 and foreign currency transaction losses of $1.0 million and $3.4 million for the years ended January 31, 2020 and 2019. We present our financial statements in U.S. dollars. Adjustments resulting from translating foreign functional currency financial statements into U.S. dollars are recorded as a separate component on our consolidated statements of comprehensive loss, net of tax. All assets and liabilities denominated in a foreign currency are translated at the exchange rate on the balance sheet date. Revenues and expenses are translated at the average exchange rate during the period. Equity transactions are translated using the historical exchange rate. |
Net Loss Per Share Attributable to Common Stockholders | Net Loss Per Share Attributable to Common Stockholders In periods when we have net income, we compute basic and diluted net loss per share in conformity with the two-class method required for participating securities. The undistributed earnings are allocated between common stock and participating securities as if all earnings had been distributed during the period presented. We consider all series of convertible preferred stock to be participating securities as the holders of such stock are entitled to receive noncumulative dividends on a pari passu basis in the event that a dividend is paid on common stock. We also consider any shares issued on the early exercise of stock options subject to repurchase to be participating securities because holders of such shares have non-forfeitable dividend rights in the event a dividend is paid on common stock. The holders of convertible preferred stock and early exercised shares do not have a contractual obligation to share in our losses. As such, our net losses in all the years presented were not allocated to these participating securities. Basic net loss per share attributable to common stockholders is computed by dividing the net loss attributable to common stockholders by the weighted-average number of shares of common stock outstanding during the period. Diluted net loss per share attributable to common stockholders is computed by giving effect to all potential shares of common stock, including shares underlying our convertible senior notes, unvested RSUs, early exercised or outstanding stock options, ESPP purchase rights, convertible preferred stock, and warrants to purchase common stock and convertible preferred stock, to the extent they are dilutive. Since we have reported net losses for all periods presented, dilutive common shares are not assumed to have been issued as their effect would have been antidilutive. Therefore, diluted net loss per share attributable to common stockholders is the same as basic net loss per share attributable to common stockholders. |
Cash and Cash Equivalents | Cash and Cash Equivalents Cash and cash equivalents consist of money market funds, highly liquid investments with original maturities of three months or less at the date of purchase and deposits with financial institutions and are carried at fair value. |
Investments | Investments Investments in marketable securities consist of commercial paper, corporate notes and bonds, as well as U.S. Treasury and government agency securities. Management determines the appropriate classification of investments at the time of purchase and reevaluates such determination at each balance sheet date. Marketable securities are classified as available-for-sale and are carried at fair value in the consolidated balance sheet and are classified as short-term or long-term based on their remaining contractual maturities. We evaluate our investments with unrealized loss positions at the individual security level to determine whether the unrealized loss was related to credit or noncredit factors. We consider whether a credit loss exists based on the extent of the unrealized loss position, any adverse conditions specifically related to the security or the issuer's operating environment, pay structure of the security, the issuer's payment history and any changes in the issuer's credit rating. Estimated credit losses are determined using a discounted cash flow model and recorded as an allowance, with changes in expected credit losses on our investments recorded in “Interest income and other income, net” in the consolidated statements of operations and comprehensive loss. Unrealized gains and losses related to noncredit factors are reflected in “Accumulated other comprehensive income (loss)” on the consolidated balance sheets. Prior to February 1, 2020, the date of the adoption of ASU 2016-13 and ASU 2019-04, we evaluated our investments to assess whether those with unrealized loss positions were other than temporarily impaired. We considered impairments to be other than temporary if they were related to deterioration in credit risk or if it is likely we will sell the securities before the recovery of their cost basis. Realized gains and losses and declines in value judged to be other than temporary were determined based on the specific identification method and reported in “Interest income and other income, net” in the consolidated statements of operations and comprehensive loss. Strategic Investments Our strategic investments consist of non-marketable equity investments in privately-held companies in which we do not have a controlling interest or significant influence. We have elected to apply the measurement alternative for equity investments that do not have readily determinable fair values, measuring them at cost, less any impairment, plus or minus adjustments resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer. An impairment loss is recorded when an event or circumstance indicates a decline in value has occurred. As of January 31, 2021 and 2020, we held equity investments in privately-held companies totaling $6.0 million and $15.5 million that are classified in “Other assets—noncurrent” on our consolidated balance sheets. As there have been no material observable price changes, we have not recorded any adjustments resulting from observable price changes for identical or similar investments or impairment charges for any of our equity investments in privately-held companies. |
Restricted Cash | Restricted CashRestricted cash consists of certificates of deposits collateralizing our operating lease agreements for office space. |
Fair Value of Financial Instruments | Fair Value of Financial Instruments We measure assets and liabilities at fair value based on an expected exit price, which represents the amount that would be received on the sale of an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value may be based on assumptions that market participants would use in pricing an asset or liability. The authoritative guidance on fair value measurements establishes a consistent framework for measuring fair value on either a recurring or nonrecurring basis whereby inputs, used in valuation techniques, are assigned a hierarchical level. The following are the hierarchical levels of inputs to measure fair value: Level 1 Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets. Level 2 Inputs reflect quoted prices for identical assets or liabilities in markets that are not active; quoted prices for similar assets or liabilities in active markets; inputs other than quoted prices that are observable for the assets or liabilities; or inputs that are derived principally from or corroborated by observable market data by correlation or other means. Level 3 Unobservable inputs reflecting our own assumptions incorporated in valuation techniques used to determine fair value. These assumptions are required to be consistent with market participant assumptions that are reasonably available Assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. Our assessment of the significance of a particular input to the fair value measurement requires judgment and may affect the placement of assets and liabilities being measured within the fair value hierarchy. The carrying values of cash, accounts receivable and accounts payable approximate their respective fair values due to the short period of time to maturity, receipt or payment. |
Accounts Receivable, Unbilled Accounts Receivable and Allowance for Doubtful Accounts | Accounts Receivable, Unbilled Accounts Receivable and Allowance for Doubtful Accounts Accounts receivable primarily consist of amounts billed currently due from customers. Our accounts receivable are subject to collection risk. Gross accounts receivable are reduced for this risk by an allowance for doubtful accounts. This allowance is for estimated losses resulting from the inability of our customers to make required payments. Our allowance for doubtful accounts includes balances that are specifically identified for adequacy based on a regular evaluation of such factors as age of the receivable balance, current economic conditions, credit quality of the customer, and past collection experience. We also include in our allowance for doubtful accounts an estimate for future credit losses, based on historical experience, which is recorded in the period in which we invoice our customers starting February 1, 2020, the date of the adoption of ASU 2016-13 and ASU 2019-04. We do not have any off-balance-sheet credit exposure related to our customers. Unbilled accounts receivable represent amounts for which we have recognized revenue, pursuant to our revenue recognition policy, and have an unconditional right to consideration prior to invoicing the customer. The unbilled accounts receivable balance was $3.6 million and $1.6 million as of January 31, 2021 and 2020. We do not typically offer right of refund in our contracts and do not require collateral from our customers. Changes in the allowance for doubtful accounts were not material in all periods presented. |
Property and Equipment | Property and Equipment Property and equipment, including costs incurred to bring to the location and condition necessary for intended use, are recorded at cost and depreciated over their estimated useful lives using the straight-line method and the following estimated useful lives: Estimated Useful Life Computer and network equipment 3 years Software, including capitalized software development costs 3 - 5 years Furniture and office equipment 3 - 4 years Leasehold improvements Lesser of lease term and 10 years Disposals are removed at cost less accumulated depreciation, and any gain or loss from disposition is reflected in the statement of operations in the year of disposition. Additions and improvements that increase the value or extend the life of an asset are capitalized. Maintenance and repairs are expensed as incurred. |
Leases | Leases On February 1, 2019, we adopted Accounting Standards Update (“ASU”) No. 2016-02, Leases (Topic 842) using the modified retrospective approach and applied the related optional practical expedients. Leases arise from contractual obligations that convey the right to control the use of identified property, plant or equipment for a period of time in exchange for consideration. We determine whether an arrangement is or contains a lease at inception, based on whether there is an identified asset and whether we control the use of the identified asset throughout the period of use. At lease commencement date, we determine lease classification between finance and operating, allocate the consideration to the lease and nonlease components and recognize a right-of-use asset and corresponding lease liability for each lease component. A right-of-use asset represents our right to use an underlying asset and a lease liability represents our obligation to make payments during the lease term. The lease liability is initially measured as the present value of the remaining lease payments over the lease term. The discount rate used to determine the present value is our incremental borrowing rate unless the interest rate implicit in the lease is readily determinable. We estimate our incremental borrowing rate based on the information available at lease commencement date for borrowings with a similar term. The right-of-use asset is initially measured as the present value of the lease payments, adjusted for initial direct costs, prepaid lease payments to lessors and lease incentives. Our operating lease right-of-use assets and liabilities recognized at February 1, 2019, the adoption date of Topic 842, were based on the present value of lease payments over the remaining lease term as of that date, using the incremental borrowing rate as of that date. We do not recognize right-of-use assets and liabilities for leases with a term of twelve months or less. Additionally, we do not separate nonlease components from the associated lease components for our office leases and certain other asset classes. The total consideration includes fixed payments and contractual escalation provisions. We are responsible for maintenance, insurance, property taxes and other variable payments, which are expensed as incurred. Our leases include options to renew or terminate. We include the option to renew or terminate in our determination of the lease term when the option is deemed to be reasonably assured to be exercised. Operating leases are classified in “Operating lease right-of-use assets”, “Operating lease liabilities—current”, and “Operating lease liabilities—noncurrent” on our consolidated balance sheets. Operating lease expense is recognized on a straight-line basis over the expected lease term and included in “Loss from operations” in our consolidated statements of operations and comprehensive loss. |
Goodwill | Goodwill Goodwill represents the excess of the purchase price over the fair value of net assets acquired in business combinations accounted for using the acquisition method of accounting and is not amortized. We test goodwill for impairment at least annually, in the fourth quarter of each year, or as events occur or circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying amount. Such events and changes may include: significant changes in performance relative to expected operating results, significant changes in asset use, significant negative industry or economic trends, and changes in our business strategy. Our test for goodwill impairment starts with a qualitative assessment to determine whether it is necessary to perform the quantitative goodwill impairment test. If qualitative factors indicate that the fair value of the reporting unit is more likely than not less than its carrying amount, then a quantitative goodwill impairment test is performed. For the purposes of impairment testing, we have determined that we have one operating segment and one reporting unit. We performed qualitative assessment for the fiscal year ended January 31, 2021, and concluded that it is more likely than not that the fair value of the reporting unit significantly exceeds its carrying value. There was no impairment of goodwill recorded in the years ended January 31, 2020 and 2019. |
Intangible Assets | Intangible Assets Intangible assets with finite lives are amortized using the straight-line method over their estimated useful lives. The estimated useful lives of intangible assets, estimated based on our expected period of benefit, are as follows: Estimated Useful Life Existing technology 3 - 5 years Customer contracts & related relationships 5 - 10 years Other (1) 1 - 5 years (1) Includes certifications, maintenance contracts and related relationships, subscription backlog and tradenames and trademarks |
Impairment of Long-Lived Assets | Impairment of Long-Lived Assets We review long-lived assets, including property and equipment and intangible assets, for impairment whenever events or changes in business circumstances indicate that the carrying amount of the asset group may not be fully recoverable. An impairment loss is recognized when estimated undiscounted future cash flows expected to result from the use of the asset and its eventual disposition are less than its carrying amount. There was no impairment of long-lived assets recognized in the periods presented. |
Software Development and Cloud Computing Arrangement Implementation Costs | Software Development and Cloud Computing Arrangement Implementation Costs We capitalize qualifying internally-developed software development costs incurred during the application development stage, as long as it is probable the project will be completed and the software will be used to perform the function intended. Capitalization of such costs ceases once the project is substantially complete and ready for its intended use. Capitalized software development costs are included in “Property and equipment, net” on our consolidated balance sheets and are amortized on a straight-line basis over their expected useful lives of approximately three We also capitalize qualifying implementation costs under cloud computing arrangements (“CCA”). Capitalization of such costs ceases once the software of the hosting arrangement is ready for its intended use. CCA implementation costs are included in “Other assets—noncurrent” on our consolidated balance sheets and are amortized on a straight-line basis over the term of the associated hosting arrangement. |
Business Combinations | Business Combinations We account for our acquisitions using the acquisition method of accounting, which requires, among other things, allocation of the fair value of purchase consideration to the tangible and intangible assets acquired and liabilities assumed at their estimated fair values on the acquisition date. The excess of the fair value of purchase consideration over the values of these identifiable assets and liabilities is recorded as goodwill. Management’s estimates of fair value are based upon assumptions believed to be reasonable, but which are inherently uncertain. During the measurement period, not to exceed one year from the date of acquisition, we may record adjustments to the assets acquired and liabilities assumed, with a corresponding offset to goodwill if new information is obtained related to facts and circumstances that existed as of the acquisition date. After the measurement period, any subsequent adjustments are reflected in the consolidated statements of operations and comprehensive loss. Acquisition costs, such as legal and consulting fees, are expensed as incurred. |
Segments | Segments Operating segments are defined as components of an entity for which separate financial information is available and that is regularly reviewed by our Chief Operating Decision Maker “CODM”) in deciding how to allocate resources to an individual segment and in assessing performance. Our Chief Executive Officer is our CODM. Our CODM reviews financial information presented on a consolidated basis for purposes of making operating decisions, allocating resources, and evaluating financial performance. As such, we have determined that we operate in one operating and one reportable segment. |
Convertible Debt | Convertible Debt We account for our convertible debt instruments as separate liability and equity components. We determined the carrying amount of the liability component as the present value of its cash flows using a discount rate based on comparable convertible transactions for similar companies. The carrying amount of the equity component representing the conversion option was calculated by deducting the fair value of the liability component from the principal amount of the convertible debt instruments as a whole. This difference represents a debt discount that is amortized to interest expense over the term of the convertible debt instruments using the effective interest rate method. The equity component is not remeasured as long as it continues to meet the conditions for equity classification. The transaction costs incurred related to the issuance of the convertible debt instruments were allocated to the liability and equity components based on their relative initial carrying value of the convertible debt instruments. Transaction costs attributable to the liability component are being amortized to interest expense over the respective terms of the convertible debt instruments, and transaction costs attributable to the equity component are netted against the equity component of the convertible debt instruments in stockholders’ equity. Capped calls entered into in connection with the offering of the convertible debt instruments are considered indexed to our own stock and are considered equity classified. They are recorded in stockholders’ equity and are not accounted for as derivatives. The cost incurred in connection with the capped calls was recorded as a reduction to additional paid-in capital. |
Legal Contingencies | Legal ContingenciesWe evaluate contingent liabilities including threatened or pending litigation and make provisions for such liabilities when it is both probable that a loss has been incurred and its amount can be reasonably estimated. We periodically assess the likelihood of any adverse judgments or outcomes from potential claims or legal proceedings, as well as potential ranges of probable losses, when the outcomes of the claims or proceedings are probable and reasonably estimable. A determination of the amount of the liabilities required, if any, for these contingencies is made after the analysis of each separate matter. |
Recent Adopted Accounting Pronouncements | Recently Adopted Accounting Pronouncements On February 1, 2020, we adopted Accounting Standards Update (“ASU”) No. 2016-13, Financial Instruments-Credit Losses (Topic 326). The Financial Accounting Standards Board (“FASB”) subsequently issued ASU No. 2019-04, Codification Improvements to Topic 326, Financial Instruments - Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments. These updates change the impairment model for most financial assets and require the use of an expected loss model in place of the previously used incurred loss method. Under this model, entities will be required to estimate the lifetime expected credit loss on such instruments and record an allowance to offset the amortized cost basis of the financial asset, resulting in a net presentation of the amount expected to be collected on the financial asset. The effect of adopting ASU 2016-13 and ASU 2019-04 on our consolidated financial statements and related disclosures was not material to the consolidated financial statements. On February 1, 2020, we adopted ASU No. 2018-15, Intangibles-Goodwill and Other-Internal-Use Software (Subtopic 350-40), which aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal use software license). The accounting for the service element of a hosting arrangement that is a service contract is not affected by the amendments in this update. The impact of prospectively adopting ASU 2018-15 on our consolidated financial statements was not material to the consolidated financial statements. Other Recent Accounting Pronouncement In August 2020, the FASB issued ASU No. 2020-06, Debt-Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40). The update removes separation models for convertible debt with a cash conversion feature and convertible instruments with a beneficial conversion feature. Such convertible debt will be accounted for as a single liability measured at its amortized cost and convertible preferred stock will be accounted for as a single equity instrument measured at its historical cost, as long as no other features require bifurcation and recognition as derivatives. The update also requires the if-converted method to be used for convertible instruments and the effect of potential share settlement be included in the diluted earnings per share calculation when an instrument may be settled in cash or shares. The amendments in this update are effective for public business entities for fiscal years beginning after December 15, 2021, and interim periods within those fiscal years. The amendment is to be adopted through either a fully retrospective or modified retrospective method of transition. Early adoption is permitted for periods beginning after December 15, 2020. We will early adopt the ASU effective February 1, 2021, using the modified retrospective method. In the consolidated balance sheets the adoption of this new guidance is estimated to result in: • an increase of approximately $77 million to the total carrying value of our convertible senior notes to reflect the full principal amount of the convertible notes outstanding net of issuance costs, • a reduction of approximately $90 million to additional paid-in capital and mezzanine equity to remove the equity component separately recorded for the conversion features associated with the convertible notes, and • a cumulative-effect adjustment of approximately $12 million to the beginning balance of accumulated deficit as of February 1, 2021. |
Summary of Significant Accoun_3
Summary of Significant Accounting Policies (Tables) | 12 Months Ended |
Jan. 31, 2021 | |
Accounting Policies [Abstract] | |
Summary Of Property, Plant and Equipment Useful Lives | Property and equipment, including costs incurred to bring to the location and condition necessary for intended use, are recorded at cost and depreciated over their estimated useful lives using the straight-line method and the following estimated useful lives: Estimated Useful Life Computer and network equipment 3 years Software, including capitalized software development costs 3 - 5 years Furniture and office equipment 3 - 4 years Leasehold improvements Lesser of lease term and 10 years |
Summary Of Finite-Lived Intangible Assets Estimated Useful Lives | The estimated useful lives of intangible assets, estimated based on our expected period of benefit, are as follows: Estimated Useful Life Existing technology 3 - 5 years Customer contracts & related relationships 5 - 10 years Other (1) 1 - 5 years (1) Includes certifications, maintenance contracts and related relationships, subscription backlog and tradenames and trademarks |
Schedule of Cash, Cash Equivalents, and Restricted Cash | The following table illustrates the reconciliation of cash, cash equivalents, and restricted cash shown in the consolidated statements of cash flows as of January 31, 2021 and 2020: January 31, (in thousands) 2021 2020 Cash and cash equivalents $ 566,055 $ 241,203 Restricted cash included in prepaid expense and other current assets — 280 Restricted cash included in other assets - noncurrent 281 — Total cash, cash equivalents, and restricted cash shown in the statement of cash flows $ 566,336 $ 241,483 |
Fair Value Measurements (Tables
Fair Value Measurements (Tables) | 12 Months Ended |
Jan. 31, 2021 | |
Fair Value Disclosures [Abstract] | |
Summary of Financial Assets Measured on Recurring Basis | The following table summarizes our financial assets that are measured at fair value on a recurring basis: January 31, 2021 (in thousands) Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Estimated Fair Value Level 1: Cash equivalents (1) Money market funds $ 284,312 $ — $ — $ 284,312 Level 2: Available-for-sale securities Commercial paper 42,048 1 (23) 42,026 Corporate notes and bonds 199,277 375 (67) 199,585 U.S. Treasury securities 4,998 — — 4,998 U.S. government agency securities 53,052 12 (6) 53,058 Level 2 total 299,375 388 (96) 299,667 Level 3: Available-for-sale securities Corporate notes and bonds 500 — — 500 Total $ 584,187 $ 388 $ (96) $ 584,479 January 31, 2020 (in thousands) Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Estimated Fair Value Level 1: Cash equivalents (1) Money market funds $ 165,424 $ — $ — $ 165,424 Level 2: Available-for-sale securities Commercial paper 14,919 7 (1) 14,925 Corporate notes and bonds 372,844 891 (31) 373,704 U.S. Treasury securities 90,697 153 (1) 90,849 U.S. government agency securities 175,086 153 (49) 175,190 Level 2 total 653,546 1,204 (82) 654,668 Total $ 818,970 $ 1,204 $ (82) $ 820,092 (1) Included in "cash and cash equivalents" in our consolidated balance sheets as of January 31, 2021 and 2020, in addition to cash of $281.7 million and $75.8 million |
Available-for-Sale Marketable Securities | The fair value of our available-for-sale securities as of January 31, 2021, by remaining contractual maturities, were as follows (in thousands): Due in one year or less $ 207,450 Due in one to two years 92,717 $ 300,167 |
Schedule of Convertible Debt | January 31, (in thousands) 2021 2020 0.5% Convertible Senior Notes due in 2023 Aggregate principal amount $ 115,000 $ 575,000 Fair value amount 373,928 743,504 0.0% Convertible Senior Notes due in 2024 Aggregate principal amount $ 690,000 $ — Fair value amount 725,100 — January 31, (in thousands) 2021 2020 2023 Notes (effective interest rate of 5.9%): Principal $ 575,000 $ 575,000 Less: extinguishment or conversion (460,000) — Unpaid principal 115,000 575,000 Less: unamortized debt discount (15,116) (101,461) Less: unamortized transaction costs (1,224) (8,218) Net carrying value of current and noncurrent liability component $ 98,660 $ 465,321 Proceeds allocated to the conversion option (debt discount) $ 134,667 $ 134,667 Less: extinguishment or conversion (31,933) — Less: transaction costs (3,336) (3,336) Net carrying value of mezzanine and permanent equity component $ 99,398 $ 131,331 Excess of if-converted value over principal $ 259,578 2024 Notes (effective interest rate of 3.8%): Principal $ 690,000 Less: unamortized debt discount (63,619) Less: unamortized transaction costs (11,353) Net carrying value of noncurrent liability component $ 615,028 Proceeds allocated to the conversion option (debt discount) $ 64,453 Less: transaction costs (1,185) Net carrying value of permanent equity component $ 63,268 Excess of if-converted value over principal $ — Interest expense recognized related to the Notes was as follows: Year Ended January 31, (in thousands) 2021 2020 2019 Contractual interest expense $ 2,773 $ 2,865 $ 1,071 Amortization of debt discount 25,828 24,411 8,795 Amortization of transaction costs 2,173 1,978 712 Total $ 30,774 $ 29,254 $ 10,578 The capped call transactions were as follows: (in thousands, except per share amounts) 2023 Notes 2024 Notes Aggregate cost of capped calls $ 67,563 $ 31,395 Initial strike price per share (1) $ 71.50 $ 420.24 Initial cap price per share (1) $ 110.00 $ 525.30 Shares of our common stock covered by the capped calls (1) 8,042 1,642 (1) Subject to adjustments for certain events, such as merger events and tender offers, and anti-dilution adjustments |
Property and Equipment, Net (Ta
Property and Equipment, Net (Tables) | 12 Months Ended |
Jan. 31, 2021 | |
Property, Plant and Equipment [Abstract] | |
Property and Equipment | Property and equipment consisted of the following: January 31, (in thousands) 2021 2020 Computer and network equipment $ 102,163 $ 66,937 Software, including capitalized software development costs 56,858 33,373 Furniture and office equipment 21,682 16,752 Leasehold improvements 79,892 59,564 260,595 176,626 Less: Accumulated depreciation (121,029) (81,228) 139,566 95,398 Work in progress 25,473 32,895 $ 165,039 $ 128,293 |
Acquisitions (Tables)
Acquisitions (Tables) | 12 Months Ended |
Jan. 31, 2021 | |
Business Combinations [Abstract] | |
Acquisition Date Fair Values of Assets Acquired and Liabilities Assumed | The following table summarizes the acquisition date fair values of assets acquired and liabilities assumed at the date of acquisition: (in thousands) As Adjusted Cash and cash equivalents $ 729 Accounts receivable 9,654 Contract assets 5,813 Prepaid expense and other assets 5,854 Property and equipment 915 Goodwill 114,663 Intangible assets 83,700 Right-of-use Assets 3,130 Accounts payable (854) Accrued compensation (2,697) Contract liabilities (7,745) Accrued expenses and other liabilities (6,499) Lease liabilities (3,126) Deferred tax liability—noncurrent (3,084) $ 200,453 |
Estimated Useful Lives | The estimated useful lives of intangible assets, primarily based on the expected period of benefit to us, and fair values of the identifiable intangible assets at acquisition date were as follows: (in thousands, except years) Estimated Fair Value Weighted Average Useful Life Existing technology $ 37,400 5 years Customer relationships—subscription 41,700 10 years Backlog—subscription 4,600 2 years Total intangible assets $ 83,700 7.3 years |
Unaudited Pro Forma Results | The unaudited pro forma results have been prepared based on estimates and assumptions, which we believe are reasonable, however, they are not necessarily indicative of the consolidated results of operations had the acquisition occurred on February 1, 2019, or of future results of operations: Year Ended January 31, (in thousands) (unaudited) 2021 2020 Revenue $ 1,464,424 $ 1,001,809 Net loss (246,819) (262,968) Net loss per share attributable to common stockholders, basic and diluted $ (1.33) $ (1.49) |
Goodwill and Intangible Asset_2
Goodwill and Intangible Assets, Net (Tables) | 12 Months Ended |
Jan. 31, 2021 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Changes in Carrying Amount of Goodwill | The changes in the carrying amount of goodwill were as follows (in thousands): Balance at January 31, 2019 $ 195,225 Foreign currency translation (343) Balance at January 31, 2020 194,882 Additions—Seal 114,663 Additions—Liveoak 39,892 Foreign currency translation 714 Balance at January 31, 2021 $ 350,151 |
Intangible Assets | Intangible assets consisted of the following: As of January 31, 2021 As of January 31, 2020 (in thousands, except years) Weighted-average Remaining Useful Life (Years) Estimated Fair Value Accumulated Amortization Acquisition-related Intangibles, Net Estimated Fair Value Accumulated Amortization Acquisition-related Intangibles, Net Existing technology 3.9 $ 72,994 $ (35,613) $ 37,381 $ 31,594 $ (25,164) $ 6,430 Customer contracts & related relationships 7.9 110,082 (29,393) 80,689 65,782 (19,071) 46,711 Other 1.2 22,534 (19,356) 3,178 17,234 (14,509) 2,725 6.5 $ 205,610 $ (84,362) 121,248 $ 114,610 $ (58,744) 55,866 Cumulative translation adjustment 580 634 Total $ 121,828 $ 56,500 |
Amortization of Finite-Lived Intangible Assets | Amortization of finite-lived intangible assets was as follows: Year Ended January 31, (in thousands) 2021 2020 2019 Cost of subscription revenue $ 11,052 $ 5,704 $ 6,081 Sales and marketing 14,566 12,013 7,021 Total $ 25,618 $ 17,717 $ 13,102 |
Future Amortization of Finite-Lived Intangibles | As of January 31, 2021, future amortization of finite-lived intangible assets that will be recorded in cost of revenue and operating expenses is estimated as follows, excluding cumulative translation adjustment: Fiscal Period Amount 2022 $ 24,282 2023 19,906 2024 18,575 2025 17,998 2026 12,388 Thereafter 28,099 Total $ 121,248 |
Deferred Contract Acquisition_2
Deferred Contract Acquisition and Fulfillment Costs (Tables) | 12 Months Ended |
Jan. 31, 2021 | |
Revenue from Contract with Customer [Abstract] | |
Deferred Contract Acquisitions Costs | The following table represents a rollforward of our deferred contract acquisition and fulfillment costs: Year Ended January 31, (in thousands) 2021 2020 Deferred Contract Acquisition Costs Beginning balance $ 155,697 $ 115,985 Additions to deferred contract acquisition costs 185,970 99,382 Amortization of deferred contract acquisition costs (81,132) (58,192) Cumulative translation adjustment 1,984 (1,478) Ending balance $ 262,519 $ 155,697 Deferred Contract Fulfillment Costs Beginning balance $ 8,218 $ 3,432 Additions to deferred contract fulfillment costs 22,540 16,341 Amortization of deferred contract fulfillment costs (18,252) (11,555) Ending balance $ 12,506 $ 8,218 |
Debt (Tables)
Debt (Tables) | 12 Months Ended |
Jan. 31, 2021 | |
Debt Disclosure [Abstract] | |
Schedule of Convertible Debt | January 31, (in thousands) 2021 2020 0.5% Convertible Senior Notes due in 2023 Aggregate principal amount $ 115,000 $ 575,000 Fair value amount 373,928 743,504 0.0% Convertible Senior Notes due in 2024 Aggregate principal amount $ 690,000 $ — Fair value amount 725,100 — January 31, (in thousands) 2021 2020 2023 Notes (effective interest rate of 5.9%): Principal $ 575,000 $ 575,000 Less: extinguishment or conversion (460,000) — Unpaid principal 115,000 575,000 Less: unamortized debt discount (15,116) (101,461) Less: unamortized transaction costs (1,224) (8,218) Net carrying value of current and noncurrent liability component $ 98,660 $ 465,321 Proceeds allocated to the conversion option (debt discount) $ 134,667 $ 134,667 Less: extinguishment or conversion (31,933) — Less: transaction costs (3,336) (3,336) Net carrying value of mezzanine and permanent equity component $ 99,398 $ 131,331 Excess of if-converted value over principal $ 259,578 2024 Notes (effective interest rate of 3.8%): Principal $ 690,000 Less: unamortized debt discount (63,619) Less: unamortized transaction costs (11,353) Net carrying value of noncurrent liability component $ 615,028 Proceeds allocated to the conversion option (debt discount) $ 64,453 Less: transaction costs (1,185) Net carrying value of permanent equity component $ 63,268 Excess of if-converted value over principal $ — Interest expense recognized related to the Notes was as follows: Year Ended January 31, (in thousands) 2021 2020 2019 Contractual interest expense $ 2,773 $ 2,865 $ 1,071 Amortization of debt discount 25,828 24,411 8,795 Amortization of transaction costs 2,173 1,978 712 Total $ 30,774 $ 29,254 $ 10,578 The capped call transactions were as follows: (in thousands, except per share amounts) 2023 Notes 2024 Notes Aggregate cost of capped calls $ 67,563 $ 31,395 Initial strike price per share (1) $ 71.50 $ 420.24 Initial cap price per share (1) $ 110.00 $ 525.30 Shares of our common stock covered by the capped calls (1) 8,042 1,642 (1) Subject to adjustments for certain events, such as merger events and tender offers, and anti-dilution adjustments |
Leases (Tables)
Leases (Tables) | 12 Months Ended |
Jan. 31, 2021 | |
Leases [Abstract] | |
Operating lease costs | The following table is a summary of our lease costs: Year Ended January 31, (in thousands) 2021 2020 Operating lease cost $ 34,034 $ 26,490 Short-term lease cost 793 837 Total lease cost $ 34,827 $ 27,327 |
Future lease payments | Future lease payments under noncancelable operating leases as of January 31, 2021, were as follows: Fiscal Period: Amount (in thousands) 2022 $ 40,603 2023 42,180 2024 39,352 2025 31,034 2026 20,254 Thereafter 53,682 Total undiscounted cash flows $ 227,105 Less: imputed interest (28,430) Present value of lease liabilities $ 198,675 |
Commitments and Contingencies (
Commitments and Contingencies (Tables) | 12 Months Ended |
Jan. 31, 2021 | |
Commitments and Contingencies Disclosure [Abstract] | |
Noncancelable Contractual Obligations | As of January 31, 2021, our future noncancelable minimum payments due under these contractual obligations with a remaining term of more than one year were as follows: Fiscal Period: Amount (in thousands) 2022 $ 17,902 2023 19,410 2024 13,638 2025 6,537 2026 5,023 Thereafter 3,145 Total $ 65,655 |
Stockholders' Equity (Tables)
Stockholders' Equity (Tables) | 12 Months Ended |
Jan. 31, 2021 | |
Equity [Abstract] | |
Share of Common Stock Reserved For Future Issuance | We have reserved the following shares of common stock, on an as-if converted basis, for future issuance as follows: January 31, (in thousands) 2021 2020 RSUs outstanding 10,962 14,246 Options issued and outstanding 4,798 6,882 Remaining shares available for future issuance under the Equity Incentive Plans 32,901 24,726 Remaining shares available for future issuance under the ESPP 6,329 4,985 Total shares of common stock reserved 54,990 50,839 |
Share-based Compensation, Activity | Shares available for grant under the 2018 Plan for the year ended January 31, 2021 was as follows: (in thousands) Year Ended Available at beginning of fiscal year 24,726 Awards authorized 9,063 Shares granted (4,032) Shares cancelled/expired 886 Shares withheld for taxes 2,258 Available at end of fiscal year 32,901 |
RSU Activity | RSU activity for the year ended January 31, 2021 was as follows: (in thousands, except per share data) Number of Units Weighted-Average Grant Date Fair Value Unvested at January 31, 2020 13,859 $ 46.28 Granted 4,022 144.80 Vested (6,318) 44.67 Canceled (977) 53.81 Unvested at January 31, 2021 10,586 $ 83.98 |
Options Activity | Option activity for the year ended January 31, 2021 was as follows: (in thousands, except per share data and years) Number of Options Weighted-Average Exercise Price Per Share Weighted-Average Remaining Contractual Term (Years) Aggregate Intrinsic Value Outstanding at January 31, 2020 6,882 $ 14.39 5.38 $ 441,247 Issued as consideration for acquisition 9 22.22 Exercised (2,072) 11.71 Canceled/expired (21) 18.09 Outstanding at January 31, 2021 4,798 $ 15.55 5.03 $ 1,042,879 Vested and expected to vest at January 31, 2021 4,798 $ 15.55 5.03 $ 1,042,801 Exercisable at January 31, 2021 4,761 $ 15.54 5.02 $ 1,034,740 |
ESPP Valuation Assumptions | We calculated the fair value of the ESPP purchase right using the Black-Scholes option-pricing model, based on the following assumptions: Year Ended January 31, 2021 2020 2019 Risk-free interest rate 0.11% - 0.17% 1.92% - 2.52 % 2.33 % Expected dividend yield — % — % — % Expected life of purchase right (in years) 0.5 0.5 0.5 Expected volatility 47% - 58% 39% - 52 % 40 % Weighted-average grant date fair value per share $90.15 - $221.20 $ 14.88 - $18.56 $ 14.24 |
Net Loss per Share Attributab_2
Net Loss per Share Attributable to Common Stockholders (Tables) | 12 Months Ended |
Jan. 31, 2021 | |
Earnings Per Share [Abstract] | |
Calculation of basic and diluted loss per share | The following table presents the calculation of basic and diluted net loss per share attributable to common stockholders for periods presented: Year Ended January 31, (in thousands, except per share data) 2021 2020 2019 Numerator: Net loss $ (243,267) $ (208,359) $ (426,458) Less: preferred stock accretion — — (353) Net loss attributable to common stockholders $ (243,267) $ (208,359) $ (426,811) Denominator: Weighted-average common shares outstanding 185,760 176,704 135,163 Net loss per share attributable to common stockholders: Basic and diluted $ (1.31) $ (1.18) $ (3.16) |
Antidilutive securities | Outstanding potentially dilutive securities that were excluded from the diluted per share calculations because they would have been antidilutive are as follows: January 31, (in thousands) 2021 2020 2019 RSUs 10,586 13,555 16,568 Stock options 4,798 6,882 13,648 ESPP 130 274 295 Convertible senior notes 3,250 788 — Total antidilutive securities 18,764 21,499 30,511 |
Income Taxes (Tables)
Income Taxes (Tables) | 12 Months Ended |
Jan. 31, 2021 | |
Income Tax Disclosure [Abstract] | |
Components of Pre-Tax Loss | The domestic and foreign components of pre-tax loss were as follows: Year Ended January 31, (in thousands) 2021 2020 2019 U.S. $ (240,175) $ (228,476) $ (460,627) International 10,683 24,920 32,419 Loss before income taxes $ (229,492) $ (203,556) $ (428,208) |
Income Tax Provision | The components of our income tax provision (benefit) were as follows: Year Ended January 31, (in thousands) 2021 2020 2019 Current Federal $ (35) $ — $ — State 269 239 413 Foreign 15,951 3,277 2,838 Total current 16,185 3,516 3,251 Deferred Federal (243) — (7,083) State 5 (43) (2) Foreign (2,172) 1,330 2,084 Total deferred (2,410) 1,287 (5,001) Provision for (benefit from) income taxes $ 13,775 $ 4,803 $ (1,750) |
Reconciliation Federal Statutory Rate | The reconciliation of the statutory federal income tax rate to our effective tax rate was as follows: Year Ended January 31, (in percentage) 2021 2020 2019 U.S statutory rate 21.0 % 21.0 % 21.0 % State taxes 2.7 3.5 3.1 Foreign tax rate differential 0.1 0.5 0.3 Increase (decrease) unrecognized tax benefit (5.6) — — Stock-based compensation 87.1 47.2 17.5 Change in valuation allowance (118.4) (80.3) (43.6) Research and development credits 9.1 8.2 4.0 Other deferred adjustment (1.1) — — Other (0.9) (2.4) (1.9) Effective tax rate (6.0) % (2.3) % 0.4 % |
Components of Net Deferred Tax Balances | The significant components of net deferred tax balances were as follows: January 31, (in thousands) 2021 2020 Deferred tax assets Net operating loss carryforwards $ 682,872 $ 423,379 Accruals and reserves 14,744 5,668 Stock-based compensation 30,377 33,405 Operating lease liability 36,148 40,495 Research and development credits 60,386 39,480 Other 14,398 7,536 Total deferred tax assets 838,925 549,963 Less: Valuation allowance (723,767) (445,746) Deferred tax assets, net of valuation allowance 115,158 104,217 Deferred tax liabilities Operating lease right-of-use asset (27,654) (32,736) Deferred contract acquisition costs (61,432) (36,567) Convertible debt (18,854) (24,737) Acquired intangibles (11,939) (13,493) Other (893) (1,457) Total deferred tax liabilities (120,772) (108,990) Net deferred tax liabilities $ (5,614) $ (4,773) |
Total Unrecognized Tax Benefits | A reconciliation of the beginning and ending balance of total unrecognized tax benefits was as follows: January 31, (in thousands) 2021 2020 Unrecognized tax benefits balance at February 1 $ 12,885 $ 9,733 Gross increase for tax positions of prior years 2,012 90 Gross decrease for tax positions of prior years — (94) Gross increase for tax positions of current year 18,882 3,156 Unrecognized tax benefits balance at January 31 $ 33,779 $ 12,885 |
Summary of Valuation Allowance | The following table represents the rollforward of our valuation allowance: Year Ended January 31, (in thousands) 2021 2020 2019 Beginning balance $ 445,746 $ 282,141 $ 119,153 Valuation allowance charged to income tax provision 269,135 163,605 201,646 Valuation allowance from acquisitions 9,354 — — Convertible senior notes settled 14,985 — — Convertible senior notes issued (15,453) — (31,594) Acquisition of SpringCM — — (7,064) Ending balance $ 723,767 $ 445,746 $ 282,141 |
Geographic Information (Tables)
Geographic Information (Tables) | 12 Months Ended |
Jan. 31, 2021 | |
Segment Reporting [Abstract] | |
Revenues by geographic area | Revenue by geographic area was as follows: Year Ended January 31, (in thousands) 2021 2020 2019 U.S. $ 1,166,004 $ 802,480 $ 581,011 International 287,043 171,491 119,958 Total revenue $ 1,453,047 $ 973,971 $ 700,969 |
Property and equipment by geographic area | Our long-lived assets by geographic area, which consist of property and equipment, net and operating lease right-of-use assets were as follows: January 31, (in thousands) 2021 2020 U.S. $ 221,549 $ 182,288 Ireland 66,670 66,925 All other countries 36,172 28,913 Total long-lived assets $ 324,391 $ 278,126 |
Summary of Significant Accoun_4
Summary of Significant Accounting Policies - Narrative (Details) | Apr. 26, 2018USD ($) | Jan. 31, 2021USD ($)reporting_unitsegment | Jan. 31, 2020USD ($) | Jan. 31, 2019USD ($) | Feb. 01, 2021USD ($) |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Advertising expense | $ 78,600,000 | $ 41,600,000 | $ 34,100,000 | ||
Foreign currency transaction gain (loss) | 1,900,000 | (1,000,000) | (3,400,000) | ||
Equity investments in privately held companies | 6,000,000 | 15,500,000 | |||
Unbilled accounts receivable | $ 3,600,000 | 1,600,000 | |||
Number of operating segments | segment | 1 | ||||
Number of reporting units | reporting_unit | 1 | ||||
Impairment of goodwill | 0 | $ 0 | |||
Number of reportable segments | segment | 1 | ||||
Additional paid in capital | $ 1,702,254,000 | 1,685,167,000 | |||
Increase in accumulated deficit | $ (1,380,452,000) | $ (1,137,185,000) | |||
Cumulative Effect, Period of Adoption, Adjustment | Subsequent Event | |||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Convertible senior notes, carrying value | $ 77,000,000 | ||||
Additional paid in capital | (90,000,000) | ||||
Increase in accumulated deficit | $ 12,000,000 | ||||
ESPP | |||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
ESPP offering period | 6 months | ||||
RSUs | |||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Accelerated share based compensation expense | $ 262,800,000 | ||||
Initial Acquisition Of Contract | |||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Commissions paid, amortization period | 5 years | ||||
Renewal Contracts | |||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Commissions paid, amortization period | 2 years | ||||
Software, including capitalized software development costs | Minimum | |||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Expected useful life | 3 years | ||||
Software, including capitalized software development costs | Maximum | |||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Expected useful life | 5 years |
Summary of Significant Accoun_5
Summary of Significant Accounting Policies - Property, plant and equipment useful life (Details) | 12 Months Ended |
Jan. 31, 2021 | |
Computer and network equipment | |
Property, Plant and Equipment [Line Items] | |
Useful life | 3 years |
Software, including capitalized software development costs | Minimum | |
Property, Plant and Equipment [Line Items] | |
Useful life | 3 years |
Software, including capitalized software development costs | Maximum | |
Property, Plant and Equipment [Line Items] | |
Useful life | 5 years |
Furniture and office equipment | Minimum | |
Property, Plant and Equipment [Line Items] | |
Useful life | 3 years |
Furniture and office equipment | Maximum | |
Property, Plant and Equipment [Line Items] | |
Useful life | 4 years |
Leasehold improvements | |
Property, Plant and Equipment [Line Items] | |
Useful life | 10 years |
Summary of Significant Accoun_6
Summary of Significant Accounting Policies - Useful lives of intangible assets (Details) | 12 Months Ended |
Jan. 31, 2021 | |
Existing technology | Minimum | |
Finite-Lived Intangible Assets [Line Items] | |
Intangible assets, useful life | 3 years |
Existing technology | Maximum | |
Finite-Lived Intangible Assets [Line Items] | |
Intangible assets, useful life | 5 years |
Other | Minimum | |
Finite-Lived Intangible Assets [Line Items] | |
Intangible assets, useful life | 1 year |
Other | Maximum | |
Finite-Lived Intangible Assets [Line Items] | |
Intangible assets, useful life | 5 years |
Customer contracts & related relationships | Minimum | |
Finite-Lived Intangible Assets [Line Items] | |
Intangible assets, useful life | 5 years |
Customer contracts & related relationships | Maximum | |
Finite-Lived Intangible Assets [Line Items] | |
Intangible assets, useful life | 10 years |
Summary of Significant Accoun_7
Summary of Significant Accounting Policies - Reconciliation of Cash, Cash Equivalents, and Restricted Cash (Details) - USD ($) $ in Thousands | Jan. 31, 2021 | Jan. 31, 2020 | Jan. 31, 2019 | Jan. 31, 2018 |
Accounting Policies [Abstract] | ||||
Cash and cash equivalents | $ 566,055 | $ 241,203 | ||
Restricted cash included in prepaid expense and other current assets | 0 | 280 | ||
Restricted cash included in other assets - noncurrent | 281 | 0 | ||
Total cash, cash equivalents, and restricted cash shown in the statement of cash flows | $ 566,336 | $ 241,483 | $ 518,178 | $ 257,436 |
Revenue and Performance Oblig_2
Revenue and Performance Obligations (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Jan. 31, 2021 | Jan. 31, 2020 | Jan. 31, 2019 | |
Disaggregation of Revenue [Line Items] | |||
Remaining performance obligations | $ 1,100 | ||
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2021-02-01 | |||
Disaggregation of Revenue [Line Items] | |||
Remaining performance obligation, percentage | 52.00% | ||
Remaining performance obligations, period of recognition | 12 months | ||
Product concentration risk | Revenue | Subscription | |||
Disaggregation of Revenue [Line Items] | |||
Concentration risk percentage | 95.00% | 94.00% | 95.00% |
Fair Value Measurements - Asset
Fair Value Measurements - Assets and liabilities measured at fair value on a recurring basis (Details) - USD ($) $ in Thousands | Jan. 31, 2021 | Jan. 31, 2020 |
Available-for-sale securities | ||
Amortized Cost | $ 584,187 | $ 818,970 |
Gross Unrealized Gains | 388 | 1,204 |
Gross Unrealized Losses | (96) | (82) |
Estimated Fair Value | 584,479 | 820,092 |
Cash | 281,700 | 75,800 |
Cash equivalents | Money market funds | Fair Value, Inputs, Level 1 | ||
Available-for-sale securities | ||
Amortized Cost | 284,312 | 165,424 |
Gross Unrealized Gains | 0 | 0 |
Gross Unrealized Losses | 0 | 0 |
Estimated Fair Value | 284,312 | 165,424 |
Available-for-sale securities | ||
Available-for-sale securities | ||
Estimated Fair Value | 300,167 | |
Available-for-sale securities | Fair Value, Inputs, Level 2 | ||
Available-for-sale securities | ||
Amortized Cost | 299,375 | 653,546 |
Gross Unrealized Gains | 388 | 1,204 |
Gross Unrealized Losses | (96) | (82) |
Estimated Fair Value | 299,667 | 654,668 |
Available-for-sale securities | Commercial paper | Fair Value, Inputs, Level 2 | ||
Available-for-sale securities | ||
Amortized Cost | 42,048 | 14,919 |
Gross Unrealized Gains | 1 | 7 |
Gross Unrealized Losses | (23) | (1) |
Estimated Fair Value | 42,026 | 14,925 |
Available-for-sale securities | Corporate notes and bonds | Fair Value, Inputs, Level 2 | ||
Available-for-sale securities | ||
Amortized Cost | 199,277 | 372,844 |
Gross Unrealized Gains | 375 | 891 |
Gross Unrealized Losses | (67) | (31) |
Estimated Fair Value | 199,585 | 373,704 |
Available-for-sale securities | Corporate notes and bonds | Fair Value, Inputs, Level 3 | ||
Available-for-sale securities | ||
Amortized Cost | 500 | |
Gross Unrealized Gains | 0 | |
Gross Unrealized Losses | 0 | |
Estimated Fair Value | 500 | |
Available-for-sale securities | U.S. Treasury securities | Fair Value, Inputs, Level 2 | ||
Available-for-sale securities | ||
Amortized Cost | 4,998 | 90,697 |
Gross Unrealized Gains | 0 | 153 |
Gross Unrealized Losses | 0 | (1) |
Estimated Fair Value | 4,998 | 90,849 |
Available-for-sale securities | U.S. government agency securities | Fair Value, Inputs, Level 2 | ||
Available-for-sale securities | ||
Amortized Cost | 53,052 | 175,086 |
Gross Unrealized Gains | 12 | 153 |
Gross Unrealized Losses | (6) | (49) |
Estimated Fair Value | $ 53,058 | $ 175,190 |
Fair Value Measurements - Fair
Fair Value Measurements - Fair Value of Marketable Securities (Details) $ in Thousands | Jan. 31, 2021USD ($)securities | Jan. 31, 2020USD ($)securities |
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Total available-for-sale securities | $ 584,479 | $ 820,092 |
Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions | securities | 42 | 0 |
Available-for-sale securities | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Due in one year or less | $ 207,450 | |
Due in one to two years | 92,717 | |
Total available-for-sale securities | $ 300,167 |
Fair Value Measurements - Narra
Fair Value Measurements - Narrative (Details) - securities | Jan. 31, 2021 | Jan. 31, 2020 |
Fair Value Disclosures [Abstract] | ||
Number of available-for-sale securities | 93 | 178 |
Fair Value Measurements - Conve
Fair Value Measurements - Convertible Senior Notes (Details) - Convertible Debt - USD ($) $ in Thousands | Jan. 31, 2021 | Jan. 31, 2020 | Sep. 30, 2018 |
Convertible Senior Notes Due 2023 | |||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | |||
Unpaid principal | $ 115,000 | $ 575,000 | |
Debt interest rate percentage | 0.50% | ||
Convertible Senior Notes Due 2023 | Fair Value, Inputs, Level 2 | |||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | |||
Convertible debt, fair value disclosures | 373,928 | 743,504 | |
Convertible Senior Notes Due 2024 | |||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | |||
Unpaid principal | $ 690,000 | 0 | |
Debt interest rate percentage | 0.00% | ||
Convertible Senior Notes Due 2024 | Fair Value, Inputs, Level 2 | |||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | |||
Convertible debt, fair value disclosures | $ 725,100 | $ 0 |
Property and Equipment, Net (De
Property and Equipment, Net (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Jan. 31, 2021 | Jan. 31, 2020 | Jan. 31, 2019 | |
Property, Plant and Equipment [Line Items] | |||
Property and equipment, net | $ 165,039 | $ 128,293 | |
Depreciation expense | 45,500 | 32,500 | $ 24,900 |
Capitalized development costs amortization expense | 6,200 | 4,100 | 2,800 |
Capitalized internally developed software | 29,300 | 17,100 | 7,600 |
Capitalized stock-based compensation costs | 7,200 | 4,100 | $ 1,900 |
Computer and network equipment | |||
Property, Plant and Equipment [Line Items] | |||
Property, plant and equipment, gross | 102,163 | 66,937 | |
Software, including capitalized software development costs | |||
Property, Plant and Equipment [Line Items] | |||
Property, plant and equipment, gross | 56,858 | 33,373 | |
Furniture and office equipment | |||
Property, Plant and Equipment [Line Items] | |||
Property, plant and equipment, gross | 21,682 | 16,752 | |
Leasehold improvements | |||
Property, Plant and Equipment [Line Items] | |||
Property, plant and equipment, gross | 79,892 | 59,564 | |
Property and equipment, excluding work in progress | |||
Property, Plant and Equipment [Line Items] | |||
Property, plant and equipment, gross | 260,595 | 176,626 | |
Less: Accumulated depreciation | (121,029) | (81,228) | |
Property and equipment, net | 139,566 | 95,398 | |
Work in progress | |||
Property, Plant and Equipment [Line Items] | |||
Property and equipment, net | $ 25,473 | $ 32,895 |
Acquisitions - Narrative (Detai
Acquisitions - Narrative (Details) - USD ($) $ in Thousands, shares in Millions | Jul. 06, 2020 | May 01, 2020 | Jan. 31, 2021 | Jan. 31, 2020 | Jan. 31, 2019 |
Business Acquisition [Line Items] | |||||
Cash paid, excluding cash acquired | $ 5,300 | $ 15,500 | $ 0 | ||
Goodwill | 350,151 | $ 194,882 | $ 195,225 | ||
Seal Software Group Limited | |||||
Business Acquisition [Line Items] | |||||
Cash paid, excluding cash acquired | $ 184,700 | ||||
Acquisition costs | 6,200 | ||||
Revenue since acquisition date | 16,300 | ||||
Earnings or loss since acquisition date | (20,100) | ||||
Goodwill | 114,663 | ||||
Seal Software Group Limited | UK Tax | |||||
Business Acquisition [Line Items] | |||||
Tax deductible amount of goodwill | 5,300 | ||||
Seal Software Group Limited | US Federal Income Tax | |||||
Business Acquisition [Line Items] | |||||
Tax deductible amount of goodwill | 0 | ||||
Seal Software Group Limited | Backlog—subscription | |||||
Business Acquisition [Line Items] | |||||
Minority investment | $ 15,000 | ||||
Liveoak Technologies | |||||
Business Acquisition [Line Items] | |||||
Acquisition costs | $ 1,800 | ||||
Consideration transferred | $ 48,400 | ||||
Goodwill | $ 39,900 | ||||
RSUs with vesting conditions | Seal Software Group Limited | |||||
Business Acquisition [Line Items] | |||||
Granted restricted stock (up to) (in shares) | 0.1 | ||||
Grant date fair value | $ 11,400 |
Acquisitions - Assets Acquired
Acquisitions - Assets Acquired and Liabilities Assumed (Details) - USD ($) $ in Thousands | Jan. 31, 2021 | Jan. 31, 2020 | Jan. 31, 2019 |
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net [Abstract] | |||
Goodwill | $ 350,151 | $ 194,882 | $ 195,225 |
Seal Software Group Limited | |||
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net [Abstract] | |||
Cash and cash equivalents | 729 | ||
Accounts receivable | 9,654 | ||
Contract assets | 5,813 | ||
Prepaid expense and other assets | 5,854 | ||
Property and equipment | 915 | ||
Goodwill | 114,663 | ||
Intangible assets | 83,700 | ||
Right-of-use Assets | 3,130 | ||
Accounts payable | (854) | ||
Accrued compensation | (2,697) | ||
Contract liabilities | (7,745) | ||
Accrued expenses and other liabilities | (6,499) | ||
Lease liabilities | (3,126) | ||
Deferred tax liability - noncurrent | (3,084) | ||
Total assets acquired and liabilities assumed | $ 200,453 |
Acquisitions - Intangible Asset
Acquisitions - Intangible Assets Acquired (Details) - Seal Software Group Limited $ in Thousands | 12 Months Ended |
Jan. 31, 2021USD ($) | |
Acquired Finite-Lived Intangible Assets [Line Items] | |
Estimated Fair Value | $ 83,700 |
Weighted Average Useful Life | 7 years 3 months 18 days |
Existing technology | |
Acquired Finite-Lived Intangible Assets [Line Items] | |
Estimated Fair Value | $ 37,400 |
Weighted Average Useful Life | 5 years |
Customer relationships—subscription | |
Acquired Finite-Lived Intangible Assets [Line Items] | |
Estimated Fair Value | $ 41,700 |
Weighted Average Useful Life | 10 years |
Backlog—subscription | |
Acquired Finite-Lived Intangible Assets [Line Items] | |
Estimated Fair Value | $ 4,600 |
Weighted Average Useful Life | 2 years |
Acquisitions - Pro Forma Result
Acquisitions - Pro Forma Results (Details) - USD ($) $ / shares in Units, $ in Thousands | 12 Months Ended | |
Jan. 31, 2021 | Jan. 31, 2020 | |
Business Acquisition, Pro Forma Information [Abstract] | ||
Revenue | $ 1,464,424 | $ 1,001,809 |
Net loss | $ (246,819) | $ (262,968) |
Net loss per share attributable to common stockholders, basic and diluted (in usd per share) | $ (1.33) | $ (1.49) |
Goodwill and Intangible Asset_3
Goodwill and Intangible Assets, Net - Goodwill (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Jan. 31, 2021 | Jan. 31, 2020 | |
Goodwill [Roll Forward] | ||
Goodwill, beginning balance | $ 194,882 | $ 195,225 |
Foreign currency translation | 714 | (343) |
Goodwill, ending balance | 350,151 | $ 194,882 |
Seal Software Group Limited | ||
Goodwill [Roll Forward] | ||
Additions | 114,663 | |
Goodwill, ending balance | 114,663 | |
Liveoak Technologies | ||
Goodwill [Roll Forward] | ||
Additions | $ 39,892 |
Goodwill and Intangible Asset_4
Goodwill and Intangible Assets, Net - Intangible Assets (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Jan. 31, 2021 | Jan. 31, 2020 | |
Finite-Lived Intangible Assets, Net [Abstract] | ||
Weighted-average Remaining Useful Life (Years) | 6 years 6 months | |
Estimated Fair Value | $ 205,610 | $ 114,610 |
Accumulated Amortization | (84,362) | (58,744) |
Acquisition-related intangibles, net, excluding cumulative translation adjustment | 121,248 | 55,866 |
Cumulative translation adjustment | 580 | 634 |
Acquisition-related Intangibles, Net | $ 121,828 | 56,500 |
Existing technology | ||
Finite-Lived Intangible Assets, Net [Abstract] | ||
Weighted-average Remaining Useful Life (Years) | 3 years 10 months 24 days | |
Estimated Fair Value | $ 72,994 | 31,594 |
Accumulated Amortization | (35,613) | (25,164) |
Acquisition-related intangibles, net, excluding cumulative translation adjustment | $ 37,381 | 6,430 |
Customer contracts & related relationships | ||
Finite-Lived Intangible Assets, Net [Abstract] | ||
Weighted-average Remaining Useful Life (Years) | 7 years 10 months 24 days | |
Estimated Fair Value | $ 110,082 | 65,782 |
Accumulated Amortization | (29,393) | (19,071) |
Acquisition-related intangibles, net, excluding cumulative translation adjustment | $ 80,689 | 46,711 |
Other | ||
Finite-Lived Intangible Assets, Net [Abstract] | ||
Weighted-average Remaining Useful Life (Years) | 1 year 2 months 12 days | |
Estimated Fair Value | $ 22,534 | 17,234 |
Accumulated Amortization | (19,356) | (14,509) |
Acquisition-related intangibles, net, excluding cumulative translation adjustment | $ 3,178 | $ 2,725 |
Goodwill and Intangible Asset_5
Goodwill and Intangible Assets, Net - Amortization (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Jan. 31, 2021 | Jan. 31, 2020 | Jan. 31, 2019 | |
Finite-Lived Intangible Assets [Line Items] | |||
Amortization of finite-lived intangible assets | $ 25,618 | $ 17,717 | $ 13,102 |
Cost of subscription revenue | |||
Finite-Lived Intangible Assets [Line Items] | |||
Amortization of finite-lived intangible assets | 11,052 | 5,704 | 6,081 |
Sales and marketing | |||
Finite-Lived Intangible Assets [Line Items] | |||
Amortization of finite-lived intangible assets | $ 14,566 | $ 12,013 | $ 7,021 |
Goodwill and Intangible Asset_6
Goodwill and Intangible Assets, Net - Future Amortization (Details) - USD ($) $ in Thousands | Jan. 31, 2021 | Jan. 31, 2020 |
Finite-Lived Intangible Assets, Amortization Expense, Maturity Schedule [Abstract] | ||
2022 | $ 24,282 | |
2023 | 19,906 | |
2024 | 18,575 | |
2025 | 17,998 | |
2026 | 12,388 | |
Thereafter | 28,099 | |
Acquisition-related intangibles, net, excluding cumulative translation adjustment | $ 121,248 | $ 55,866 |
Contract Balances (Details)
Contract Balances (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Jan. 31, 2021 | Jan. 31, 2020 | Jan. 31, 2019 | |
Revenue from Contract with Customer [Abstract] | |||
Contract assets | $ 17.5 | $ 13.4 | |
Contract assets, noncurrent | 0.6 | 0.9 | |
Revenue recognized that was included in contract liability balance at the beginning of the period | $ 499.5 | $ 374.8 | $ 264 |
Payment term | 30 days |
Deferred Contract Acquisition_3
Deferred Contract Acquisition and Fulfillment Costs (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Jan. 31, 2021 | Jan. 31, 2020 | Jan. 31, 2019 | |
Capitalized Contract Cost, Net [Roll Forward] | |||
Amortization of deferred contract acquisitions and fulfillments costs | $ (99,384) | $ (69,747) | $ (42,112) |
Contract acquisition costs | |||
Capitalized Contract Cost, Net [Roll Forward] | |||
Beginning balance | 155,697 | 115,985 | |
Additions to deferred contract acquisition and fulfillment costs | 185,970 | 99,382 | |
Amortization of deferred contract acquisitions and fulfillments costs | (81,132) | (58,192) | |
Cumulative translation adjustment | 1,984 | (1,478) | |
Ending balance | 262,519 | 155,697 | 115,985 |
Contract fulfillment costs | |||
Capitalized Contract Cost, Net [Roll Forward] | |||
Beginning balance | 8,218 | 3,432 | |
Additions to deferred contract acquisition and fulfillment costs | 22,540 | 16,341 | |
Amortization of deferred contract acquisitions and fulfillments costs | (18,252) | (11,555) | |
Ending balance | $ 12,506 | $ 8,218 | $ 3,432 |
Debt - Narrative (Details)
Debt - Narrative (Details) $ / shares in Units, shares in Millions | 1 Months Ended | 12 Months Ended | |||
Jan. 31, 2021USD ($)$ / shares | Sep. 30, 2018USD ($)day$ / shares | Jan. 31, 2021USD ($)$ / sharesshares | Jan. 31, 2020USD ($) | Jan. 31, 2019USD ($) | |
Debt Conversion [Line Items] | |||||
Proceeds from issuance of debt | $ 677,370,000 | $ 0 | $ 560,756,000 | ||
Repayments of convertible debt | 384,199,000 | 0 | 0 | ||
Stock issued as repayment of convertible debt, value | 524,979,000 | ||||
Fair value of shares issued as part of the repayments of convertible senior notes | 1,233,990,000 | 0 | 0 | ||
Loss on extinguishment of debt | (33,752,000) | 0 | $ 0 | ||
Convertible debt reclassified to convertible senior notes, current | $ 20,469,000 | $ 20,469,000 | 0 | ||
Minimum | |||||
Debt Conversion [Line Items] | |||||
Commitment fee percentage | 0.25% | ||||
Maximum | |||||
Debt Conversion [Line Items] | |||||
Commitment fee percentage | 0.30% | ||||
Convertible Debt | Convertible Senior Notes Due 2023 | |||||
Debt Conversion [Line Items] | |||||
Repayments of convertible debt | $ 460,000,000 | ||||
Debt conversion, converted instrument, amount | 23,900,000 | 1,700,000,000 | |||
Cash payments to extinguish debt | $ 459,200,000 | ||||
Stock issued as repayment of convertible debt (in shares) | shares | 4.7 | ||||
Stock issued as repayment of convertible debt, value | $ 1,200,000,000 | ||||
Loss on extinguishment of debt | (33,800,000) | ||||
Convertible Debt | Reclassification from Noncurrent to Current | Convertible Senior Notes Due 2023 | |||||
Debt Conversion [Line Items] | |||||
Convertible debt reclassified to convertible senior notes, current | 20,500,000 | 20,500,000 | |||
Convertible Debt | Reclassification from Permanent Equity to Mezzanine Equity | Convertible Senior Notes Due 2023 | |||||
Debt Conversion [Line Items] | |||||
Convertible debt reclassified to mezzanine equity from permanent equity | 3,400,000 | 3,400,000 | |||
Line of Credit | Revolving Credit Facility | |||||
Debt Conversion [Line Items] | |||||
Maximum borrowing capacity | 500,000,000 | 500,000,000 | |||
Accordion feature, increase limit | 250,000,000 | 250,000,000 | |||
Convertible Senior Notes Due 2023 | Convertible Debt | |||||
Debt Conversion [Line Items] | |||||
Aggregate principal amount of debt issued | 575,000,000 | $ 575,000,000 | 575,000,000 | 575,000,000 | |
Debt interest rate percentage | 0.50% | ||||
Additional principal amount purchased | $ 75,000,000 | ||||
Proceeds from issuance of debt | $ 560,800,000 | ||||
Conversion price (in usd per share) | $ / shares | $ 71.50 | ||||
Percentage of principal amount redeemable | 100.00% | ||||
Trading days | day | 20 | ||||
Consecutive trading days | day | 30 | ||||
Percentage of conversion price | 130.00% | ||||
Convertible debt reclassified to mezzanine equity from permanent equity | $ 99,398,000 | $ 99,398,000 | $ 131,331,000 | ||
Convertible Senior Notes Due 2024 | Convertible Debt | |||||
Debt Conversion [Line Items] | |||||
Debt interest rate percentage | 0.00% | 0.00% | |||
Additional principal amount purchased | $ 90,000,000 | $ 90,000,000 | |||
Proceeds from issuance of debt | $ 677,300,000 | ||||
Conversion price (in usd per share) | $ / shares | $ 420.24 | $ 420.24 | |||
Convertible debt reclassified to mezzanine equity from permanent equity | $ 63,268,000 | $ 63,268,000 | |||
Capped Calls | Convertible Senior Notes Due 2023 | |||||
Debt Conversion [Line Items] | |||||
Initial cap price (in usd per share) | $ / shares | $ 110 | $ 110 | |||
Capped Calls | Convertible Senior Notes Due 2024 | |||||
Debt Conversion [Line Items] | |||||
Initial cap price (in usd per share) | $ / shares | $ 525.30 | $ 525.30 | |||
Conversion Covenant One | Convertible Senior Notes Due 2023 | Convertible Debt | |||||
Debt Conversion [Line Items] | |||||
Trading days | day | 20 | ||||
Consecutive trading days | day | 30 | ||||
Percentage of conversion price | 130.00% | ||||
Conversion Covenant Two | Convertible Senior Notes Due 2023 | Convertible Debt | |||||
Debt Conversion [Line Items] | |||||
Trading days | day | 5 | ||||
Consecutive trading days | day | 10 | ||||
Percentage of conversion price | 98.00% |
Debt - Carrying Value of Liabil
Debt - Carrying Value of Liability Component (Details) - Convertible Debt - USD ($) | Jan. 31, 2021 | Jan. 31, 2020 | Sep. 30, 2018 |
Convertible Senior Notes Due 2023 | |||
Debt Instrument [Line Items] | |||
Principal | $ 575,000,000 | $ 575,000,000 | $ 575,000,000 |
Less: extinguishment or conversion | (460,000,000) | 0 | |
Unpaid principal | 115,000,000 | 575,000,000 | |
Less: unamortized debt discount | (15,116,000) | (101,461,000) | |
Less: unamortized transaction costs | (1,224,000) | (8,218,000) | |
Net carrying value of current and noncurrent liability component | 98,660,000 | 465,321,000 | |
Convertible Senior Notes Due 2024 | |||
Debt Instrument [Line Items] | |||
Unpaid principal | 690,000,000 | $ 0 | |
Less: unamortized debt discount | (63,619,000) | ||
Less: unamortized transaction costs | (11,353,000) | ||
Net carrying value of current and noncurrent liability component | $ 615,028,000 |
Debt - Carrying Amount Of Equit
Debt - Carrying Amount Of Equity Component (Details) - Convertible Debt - USD ($) $ in Thousands | 12 Months Ended | |
Jan. 31, 2021 | Jan. 31, 2020 | |
Convertible Senior Notes Due 2023 | ||
Debt Instrument [Line Items] | ||
Proceeds allocated to the conversion option (debt discount) | $ 134,667 | $ 134,667 |
Less: extinguishment or conversion | (31,933) | 0 |
Less: transaction costs | (3,336) | (3,336) |
Net carrying value of mezzanine and permanent equity component | 99,398 | $ 131,331 |
Excess of if-converted value over principal | $ 259,578 | |
Debt interest rate percentage | 5.90% | 5.90% |
Convertible Senior Notes Due 2024 | ||
Debt Instrument [Line Items] | ||
Proceeds allocated to the conversion option (debt discount) | $ 64,453 | |
Less: transaction costs | (1,185) | |
Net carrying value of mezzanine and permanent equity component | 63,268 | |
Excess of if-converted value over principal | $ 0 | |
Debt interest rate percentage | 3.80% |
Debt - Interest Expense (Detail
Debt - Interest Expense (Details) - Convertible Debt - Convertible Senior Notes Due 2023 - USD ($) $ in Thousands | 12 Months Ended | ||
Jan. 31, 2021 | Jan. 31, 2020 | Jan. 31, 2019 | |
Debt Instrument [Line Items] | |||
Contractual interest expense | $ 2,773 | $ 2,865 | $ 1,071 |
Amortization of debt discount | 25,828 | 24,411 | 8,795 |
Amortization of transaction costs | 2,173 | 1,978 | 712 |
Total | $ 30,774 | $ 29,254 | $ 10,578 |
Debt - Capped Calls (Details)
Debt - Capped Calls (Details) - Capped Calls $ / shares in Units, shares in Thousands, $ in Thousands | 12 Months Ended |
Jan. 31, 2021USD ($)$ / sharesshares | |
Convertible Senior Notes Due 2023 | |
Debt Instrument [Line Items] | |
Aggregate cost of capped calls | $ | $ 67,563 |
Initial strike price per share (in usd per share) | $ 71.50 |
Initial cap price per share (in usd per share) | $ 110 |
Shares of our common stock covered by the capped calls (in shares) | shares | 8,042 |
Convertible Senior Notes Due 2024 | |
Debt Instrument [Line Items] | |
Aggregate cost of capped calls | $ | $ 31,395 |
Initial strike price per share (in usd per share) | $ 420.24 |
Initial cap price per share (in usd per share) | $ 525.30 |
Shares of our common stock covered by the capped calls (in shares) | shares | 1,642 |
Leases - Leases Costs (Details)
Leases - Leases Costs (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Jan. 31, 2021 | Jan. 31, 2020 | |
Leases [Abstract] | ||
Operating lease cost | $ 34,034 | $ 26,490 |
Short-term lease cost | 793 | 837 |
Total lease cost | $ 34,827 | $ 27,327 |
Leases - Narrative (Details)
Leases - Narrative (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Jan. 31, 2019 | Jan. 31, 2021 | Jan. 31, 2020 | |
Leases [Abstract] | |||
Rent expense | $ 19.8 | ||
Operating lease, weighted average remaining lease term (in years) | 6 years 7 months 6 days | 7 years 8 months 12 days | |
Weighted average discount rate | 4.30% | 4.40% |
Leases - Future Lease Payments
Leases - Future Lease Payments - Topic 842 (Details) $ in Thousands | Jan. 31, 2021USD ($) |
Leases [Abstract] | |
2022 | $ 40,603 |
2023 | 42,180 |
2024 | 39,352 |
2025 | 31,034 |
2026 | 20,254 |
Thereafter | 53,682 |
Total undiscounted cash flows | 227,105 |
Less: imputed interest | (28,430) |
Present value of lease liabilities | $ 198,675 |
Commitments and Contingencies_2
Commitments and Contingencies (Details) $ in Thousands | Jan. 31, 2021USD ($) |
Commitments and Contingencies Disclosure [Abstract] | |
Letters of credit outstanding | $ 7,400 |
Purchase Obligation, Fiscal Year Maturity [Abstract] | |
2022 | 17,902 |
2023 | 19,410 |
2024 | 13,638 |
2025 | 6,537 |
2026 | 5,023 |
Thereafter | 3,145 |
Total | $ 65,655 |
Stockholders' Equity - Narrativ
Stockholders' Equity - Narrative (Details) $ / shares in Units, $ in Thousands | May 01, 2018shares | Apr. 26, 2018 | Jan. 31, 2021USD ($)plan$ / sharesshares | Jan. 31, 2020USD ($)$ / sharesshares | Jan. 31, 2019USD ($)$ / sharesshares | Feb. 01, 2021shares |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||
Redeemable convertible preferred stock, shares issued (in shares) | 100,200,000 | |||||
Number of stock-based compensation plans | plan | 3 | |||||
Unrecognized compensation cost, options | $ | $ 200 | |||||
Intrinsic value of options exercised | $ | 302,400 | $ 325,700 | $ 171,600 | |||
Grant date fair value of options vested | $ | $ 7,500 | 10,500 | 25,800 | |||
Percent of purchase price of fair value of common stock | 85.00% | |||||
Employee stock purchase plan, compensation expense | $ | $ 286,877 | $ 206,404 | $ 410,978 | |||
Reserved for future issuance (in shares) | 54,990,000 | 50,839,000 | ||||
RSUs | ||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||
Vesting period | 4 years | |||||
Weighted average grant date fair value of RSUs (in usd per share) | $ / shares | $ 144.80 | $ 56.05 | $ 53.77 | |||
Grant date fair value | $ | $ 282,300 | $ 223,000 | $ 260,800 | |||
Unrecognized compensation cost, RSUs | $ | $ 680,700 | |||||
Unrecognized compensation cost, remaining weighted-average period for recognition | 2 years 2 months 12 days | |||||
Reserved for future issuance (in shares) | 10,962,000 | 14,246,000 | ||||
Stock options | ||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||
Unrecognized compensation cost, remaining weighted-average period for recognition | 2 months 12 days | |||||
ESPP offering period | 6 months | |||||
Reserved for future issuance (in shares) | 4,798,000 | 6,882,000 | ||||
ESPP | ||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||
Annual increase in shares reserved, percentage of total shares | 1.00% | |||||
Increase in shares reserved for issuance (in shares) | 3,800,000 | |||||
Weighted average grant date fair value of RSUs (in usd per share) | $ / shares | $ 14.24 | |||||
Employee contribution, maximum percentage of earnings | 15.00% | |||||
ESPP offering period | 6 months | |||||
Employee stock purchase plan, compensation expense | $ | $ 12,600 | $ 8,900 | $ 2,900 | |||
Reserved for future issuance (in shares) | 6,329,000 | 4,985,000 | ||||
2018 Plan | ||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||
Annual increase in shares reserved, percentage of total shares | 5.00% | |||||
2018 Plan | Subsequent Event | ||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||
Increase in shares reserved for issuance (in shares) | 9,600,000 | |||||
2018 Plan | RSUs | ||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||
Annual vesting percentage | 25.00% | |||||
Vesting period | 1 year | |||||
Common Stock | ||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||
Shares issued upon conversion (in shares) | 100,400,000 | 4,698,000 | 100,350,000 |
Stockholders' Equity - Common S
Stockholders' Equity - Common Stock Reserved For Future Issuance (Details) - shares shares in Thousands | Jan. 31, 2021 | Jan. 31, 2020 |
Class of Stock [Line Items] | ||
Reserved for future issuance (in shares) | 54,990 | 50,839 |
RSUs | ||
Class of Stock [Line Items] | ||
Reserved for future issuance (in shares) | 10,962 | 14,246 |
Stock options | ||
Class of Stock [Line Items] | ||
Reserved for future issuance (in shares) | 4,798 | 6,882 |
ESPP | ||
Class of Stock [Line Items] | ||
Reserved for future issuance (in shares) | 6,329 | 4,985 |
Remaining shares available for future issuance under the Equity Incentive Plans | ||
Class of Stock [Line Items] | ||
Reserved for future issuance (in shares) | 32,901 | 24,726 |
Stockholders' Equity - Equity A
Stockholders' Equity - Equity Awards Available For Grants (Details) shares in Thousands | 12 Months Ended |
Jan. 31, 2021shares | |
Number Of Shares Available For Grant [Roll Forward] | |
Available at beginning of fiscal year (in shares) | 24,726 |
Awards authorized (in shares) | 9,063 |
Shares granted (in shares) | (4,032) |
Shares canceled/expired (in shares) | 21 |
Available at end of fiscal year (in shares) | 32,901 |
RSUs | |
Number Of Shares Available For Grant [Roll Forward] | |
Shares granted (in shares) | (4,022) |
Shares canceled/expired (in shares) | 886 |
Shares withheld for taxes (in shares) | 2,258 |
Vesting period | 4 years |
Stockholders' Equity - Stock Op
Stockholders' Equity - Stock Option Activity (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands | 12 Months Ended | |
Jan. 31, 2021 | Jan. 31, 2020 | |
Number of Options | ||
Beginning balance (in shares) | 6,882 | |
Options issued (in shares) | 9 | |
Options exercised (in shares) | (2,072) | |
Options canceled/expired (in shares) | (21) | |
Ending balance (in shares) | 4,798 | 6,882 |
Vested and expected to vest (in shares) | 4,798 | |
Exercisable (in shares) | 4,761 | |
Weighted-Average Exercise Price Per Share | ||
Beginning balance (in usd per share) | $ 14.39 | |
Options issued (in usd per share) | 22.22 | |
Options exercised (in usd per share) | 11.71 | |
Options canceled/expired (in usd per share) | 18.09 | |
Ending balance (in usd per share) | 15.55 | $ 14.39 |
Vested and expected to vest (in usd per share) | 15.55 | |
Exercisable (in usd per share) | $ 15.54 | |
Weighted-Average Remaining Contractual Term | ||
Balance | 5 years 10 days | 5 years 4 months 17 days |
Vested and expected to vest | 5 years 10 days | |
Exercisable | 5 years 7 days | |
Aggregate Intrinsic Value | ||
Balance | $ 1,042,879 | $ 441,247 |
Vested and expected to vest | 1,042,801 | |
Exercisable | $ 1,034,740 |
Stockholders' Equity - RSU Acti
Stockholders' Equity - RSU Activity (Details) - $ / shares shares in Thousands | 12 Months Ended | ||
Jan. 31, 2021 | Jan. 31, 2020 | Jan. 31, 2019 | |
Number of Units | |||
Granted (in shares) | 4,032 | ||
RSUs | |||
Number of Units | |||
Unvested at beginning of period (in shares) | 13,859 | ||
Granted (in shares) | 4,022 | ||
Vested (in shares) | (6,318) | ||
Canceled (in shares) | (977) | ||
Unvested at end of period (in shares) | 10,586 | 13,859 | |
Weighted-Average Grant Date Fair Value | |||
Unvested at beginning of period (in usd per share) | $ 46.28 | ||
Granted (in usd per share) | 144.80 | $ 56.05 | $ 53.77 |
Vested (in usd per share) | 44.67 | ||
Canceled (in usd per share) | 53.81 | ||
Unvested at end of period (in usd per share) | $ 83.98 | $ 46.28 |
Stockholders' Equity - Valuatio
Stockholders' Equity - Valuation Assumptions (Details) - ESPP - $ / shares | 12 Months Ended | ||
Jan. 31, 2021 | Jan. 31, 2020 | Jan. 31, 2019 | |
Class of Stock [Line Items] | |||
Risk-free interest rate, minimum | 0.11% | 1.92% | |
Risk-free interest rate, maximum | 0.17% | 2.52% | |
Risk-free interest rate | 2.33% | ||
Expected dividend yield | 0.00% | 0.00% | 0.00% |
Expected life of purchase right (in years) | 6 months | 6 months | 6 months |
Expected volatility, minimum | 47.00% | 39.00% | |
Expected volatility, maximum | 58.00% | 52.00% | |
Expected volatility | 40.00% | ||
Granted (in usd per share) | $ 14.24 | ||
Minimum | |||
Class of Stock [Line Items] | |||
Granted (in usd per share) | $ 90.15 | $ 14.88 | |
Maximum | |||
Class of Stock [Line Items] | |||
Granted (in usd per share) | $ 221.20 | $ 18.56 |
Net Loss per Share Attributab_3
Net Loss per Share Attributable to Common Stockholders - Calculation of basic and diluted net loss per share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands | 12 Months Ended | ||
Jan. 31, 2021 | Jan. 31, 2020 | Jan. 31, 2019 | |
Numerator: | |||
Net loss | $ (243,267) | $ (208,359) | $ (426,458) |
Less: preferred stock accretion | 0 | 0 | (353) |
Net loss attributable to common stockholders | $ (243,267) | $ (208,359) | $ (426,811) |
Denominator: | |||
Weighted-average common shares outstanding (in shares) | 185,760 | 176,704 | 135,163 |
Net loss per share attributable to common stockholders: | |||
Basic and diluted (in usd per share) | $ (1.31) | $ (1.18) | $ (3.16) |
Net Loss per Share Attributab_4
Net Loss per Share Attributable to Common Stockholders - Antidilutive Securities (Details) - shares shares in Thousands | 12 Months Ended | ||
Jan. 31, 2021 | Jan. 31, 2020 | Jan. 31, 2019 | |
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | |||
Antidilutive securities (in shares) | 18,764 | 21,499 | 30,511 |
RSUs | |||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | |||
Antidilutive securities (in shares) | 10,586 | 13,555 | 16,568 |
Stock options | |||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | |||
Antidilutive securities (in shares) | 4,798 | 6,882 | 13,648 |
ESPP | |||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | |||
Antidilutive securities (in shares) | 130 | 274 | 295 |
Convertible senior notes | |||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | |||
Antidilutive securities (in shares) | 3,250 | 788 | 0 |
Employee Benefit Plan (Details)
Employee Benefit Plan (Details) - USD ($) $ in Millions | 3 Months Ended | 12 Months Ended | ||
Jan. 31, 2021 | Jan. 31, 2021 | Jan. 31, 2020 | Jan. 31, 2019 | |
Postemployment Benefits [Abstract] | ||||
Percentage of participant's contribution matched by employer | 50.00% | |||
Employer matching contribution, maximum percentage of participant's base salary | 6.00% | |||
Defined contribution plan expense | $ 18.9 | $ 11 | $ 1.7 |
Income Taxes - Additional Infor
Income Taxes - Additional Information (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Jan. 31, 2021 | Jan. 31, 2020 | Jan. 31, 2019 | |
Operating Loss Carryforwards [Line Items] | |||
Employee stock purchase plan, compensation expense | $ 286,877 | $ 206,404 | $ 410,978 |
Tax benefit from compensation expense | 2,200 | 1,000 | 1,700 |
Unrecognized tax benefits that would affect tax rate, if recognized | 15,900 | ||
Liability for uncertain tax positions | 16,700 | 3,300 | $ 2,900 |
Accrued interest and penalties | 800 | ||
Increase (decrease) in valuation allowance | 278,000 | $ 163,600 | |
Domestic Tax Authority | |||
Operating Loss Carryforwards [Line Items] | |||
Operating loss carryforwards | 2,800,000 | ||
Operating loss carryforwards not limited to 80% of taxable income | 2,300,000 | ||
Research tax credit carryforwards | 63,900 | ||
State and Local Jurisdiction | |||
Operating Loss Carryforwards [Line Items] | |||
Operating loss carryforwards | 1,300,000 | ||
Research tax credit carryforwards | 17,000 | ||
Foreign Tax Authority | |||
Operating Loss Carryforwards [Line Items] | |||
Operating loss carryforwards | $ 38,000 |
Income Taxes - Components of Pr
Income Taxes - Components of Pre-Tax Loss (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Jan. 31, 2021 | Jan. 31, 2020 | Jan. 31, 2019 | |
Income Tax Disclosure [Abstract] | |||
U.S. | $ (240,175) | $ (228,476) | $ (460,627) |
International | 10,683 | 24,920 | 32,419 |
Loss before provision for (benefit from) income taxes | $ (229,492) | $ (203,556) | $ (428,208) |
Income Taxes - Components of In
Income Taxes - Components of Income Tax Provision (Benefit) (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Jan. 31, 2021 | Jan. 31, 2020 | Jan. 31, 2019 | |
Current | |||
Federal | $ (35) | $ 0 | $ 0 |
State | 269 | 239 | 413 |
Foreign | 15,951 | 3,277 | 2,838 |
Total current | 16,185 | 3,516 | 3,251 |
Deferred | |||
Federal | (243) | 0 | (7,083) |
State | 5 | (43) | (2) |
Foreign | (2,172) | 1,330 | 2,084 |
Total deferred | (2,410) | 1,287 | (5,001) |
Provision for (benefit from) income taxes | $ 13,775 | $ 4,803 | $ (1,750) |
Income Taxes - Effective Income
Income Taxes - Effective Income Tax Rate Reconciliation (Details) | 12 Months Ended | ||
Jan. 31, 2021 | Jan. 31, 2020 | Jan. 31, 2019 | |
Effective Income Tax Rate Reconciliation, Percent [Abstract] | |||
U.S statutory rate | 21.00% | 21.00% | 21.00% |
State taxes | 2.70% | 3.50% | 3.10% |
Foreign tax rate differential | 0.10% | 0.50% | 0.30% |
Increase (decrease) unrecognized tax benefit | (5.60%) | 0.00% | 0.00% |
Stock-based compensation | 87.10% | 47.20% | 17.50% |
Change in valuation allowance | (118.40%) | (80.30%) | (43.60%) |
Research and development credits | 9.10% | 8.20% | 4.00% |
Other deferred adjustment | (1.10%) | 0.00% | 0.00% |
Other | (0.90%) | (2.40%) | (1.90%) |
Effective tax rate | (6.00%) | (2.30%) | 0.40% |
Income Taxes - Components of Ne
Income Taxes - Components of Net Deferred Tax Balances (Details) - USD ($) $ in Thousands | Jan. 31, 2021 | Jan. 31, 2020 | Jan. 31, 2019 | Jan. 31, 2018 |
Deferred tax assets | ||||
Net operating loss carryforwards | $ 682,872 | $ 423,379 | ||
Accruals and reserves | 14,744 | 5,668 | ||
Stock-based compensation | 30,377 | 33,405 | ||
Operating lease liability | 36,148 | 40,495 | ||
Research and development credits | 60,386 | 39,480 | ||
Other | 14,398 | 7,536 | ||
Total deferred tax assets | 838,925 | 549,963 | ||
Less: Valuation allowance | (723,767) | (445,746) | $ (282,141) | $ (119,153) |
Deferred tax assets, net of valuation allowance | 115,158 | 104,217 | ||
Deferred tax liabilities | ||||
Operating lease right-of-use asset | (27,654) | (32,736) | ||
Deferred contract acquisition costs | (61,432) | (36,567) | ||
Convertible debt | (18,854) | (24,737) | ||
Acquired intangibles | (11,939) | (13,493) | ||
Other | (893) | (1,457) | ||
Total deferred tax liabilities | (120,772) | (108,990) | ||
Net deferred tax liabilities | $ (5,614) | $ (4,773) |
Income Taxes - Unrecognized Tax
Income Taxes - Unrecognized Tax Benefits (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Jan. 31, 2021 | Jan. 31, 2020 | |
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward] | ||
Unrecognized tax benefits balance at February 1 | $ 12,885 | $ 9,733 |
Gross increase for tax positions of prior years | 2,012 | 90 |
Gross decrease for tax positions of prior years | 0 | (94) |
Gross increase for tax positions of current year | 18,882 | 3,156 |
Unrecognized tax benefits balance at January 31 | $ 33,779 | $ 12,885 |
Income Taxes - Valuation Allowa
Income Taxes - Valuation Allowance (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Jan. 31, 2021 | Jan. 31, 2020 | Jan. 31, 2019 | |
Deferred Tax Assets, Valuation Allowance [Roll Forward] | |||
Beginning balance | $ 445,746 | $ 282,141 | $ 119,153 |
Valuation allowance charged to income tax provision | 269,135 | 163,605 | 201,646 |
Valuation allowance from acquisitions | 9,354 | 0 | 0 |
Convertible senior notes settled | 14,985 | 0 | 0 |
Convertible senior notes issued | (15,453) | 0 | (31,594) |
Acquisition of SpringCM | 0 | 0 | (7,064) |
Ending balance | $ 723,767 | $ 445,746 | $ 282,141 |
Geographic Information (Details
Geographic Information (Details) $ in Thousands | 12 Months Ended | ||
Jan. 31, 2021USD ($)segment | Jan. 31, 2020USD ($) | Jan. 31, 2019USD ($) | |
Revenues from External Customers and Long-Lived Assets [Line Items] | |||
Number of operating segments | segment | 1 | ||
Number of reportable segments | segment | 1 | ||
Total revenue | $ 1,453,047 | $ 973,971 | $ 700,969 |
Total long-lived assets | 324,391 | 278,126 | |
U.S. | |||
Revenues from External Customers and Long-Lived Assets [Line Items] | |||
Total revenue | 1,166,004 | 802,480 | 581,011 |
Total long-lived assets | 221,549 | 182,288 | |
Ireland | |||
Revenues from External Customers and Long-Lived Assets [Line Items] | |||
Total long-lived assets | 66,670 | 66,925 | |
International | |||
Revenues from External Customers and Long-Lived Assets [Line Items] | |||
Total revenue | 287,043 | 171,491 | $ 119,958 |
Total long-lived assets | $ 36,172 | $ 28,913 |
Subsequent Events (Details)
Subsequent Events (Details) - USD ($) $ in Thousands, shares in Millions | 1 Months Ended | 2 Months Ended | 3 Months Ended | 12 Months Ended | |||
Jan. 31, 2021 | Mar. 31, 2021 | Mar. 25, 2021 | Jul. 31, 2021 | Jan. 31, 2021 | Jan. 31, 2020 | Jan. 31, 2019 | |
Subsequent Event [Line Items] | |||||||
Repayments of convertible debt | $ 384,199 | $ 0 | $ 0 | ||||
Stock issued as repayment of convertible debt, value | $ 524,979 | ||||||
Convertible Debt | Convertible Senior Notes Due 2023 | |||||||
Subsequent Event [Line Items] | |||||||
Debt conversion, converted instrument, amount | $ 23,900 | 1,700,000 | |||||
Repayments of convertible debt | 460,000 | ||||||
Cash payments to extinguish debt | $ 459,200 | ||||||
Stock issued as repayment of convertible debt (in shares) | 4.7 | ||||||
Stock issued as repayment of convertible debt, value | $ 1,200,000 | ||||||
Subsequent Event | Convertible Debt | Convertible Senior Notes Due 2023 | |||||||
Subsequent Event [Line Items] | |||||||
Debt conversion, converted instrument, amount | $ 12,800 | $ 72,300 | $ 6,600 | ||||
Repayments of convertible debt | 23,900 | ||||||
Cash payments to extinguish debt | $ 23,900 | ||||||
Stock issued as repayment of convertible debt (in shares) | 0.2 | ||||||
Stock issued as repayment of convertible debt, value | $ 48,400 |